Clostridial toxins

Bibliography

• 1  Brüggemann H, Bäumer S, Fricke WF et al.: The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl Acad. Sci. USA100,1316–1321 (2003).
  MedlineGoogle Scholar
• 2  Brüggemann H, Gottschalk G: Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani. Anaerobe10,53–68 (2004).
  MedlineGoogle Scholar
• 3  Sebaihia M, Peck MW, Minton NP et al.: Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res.17,1082–1092 (2007).
  Medline CASGoogle Scholar
• 4  Sebaihia M, Wren BW, Mullany P et al.: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet.38,779–786 (2006).
  MedlineGoogle Scholar
• 5  Shimizu T, Ohtani K, Hirakawa H et al.: Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl Acad. Sci. USA99,996–1001 (2002).
  Medline CASGoogle Scholar
• 6  Stackebrandt E, Hippe H: Taxonomy and systematics. In: Clostridia. Bahl H, Dürre P (Eds). Willey-VCH, Weinheim, Germany, 19–48 (2001).
  Google Scholar
• 7  Popoff MR, Stiles BG: Clostridial toxins vs. other bacterial toxins. In: Handbook of Clostridia. Dürre P (Ed.). Taylor and Francis, FL, USA, 323–383 (2005).
  Google Scholar
• 8  Songer JG: Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev.9,216–234 (1996).
  Medline CASGoogle Scholar
• 9  Geny B, Popoff MR: Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol. Cell98,667–678 (2006).
  Medline CASGoogle Scholar
• 10  Deguchi A, Miyamoto K, Kuwahara T et al.: Genetic characterization of type A enterotoxigenic Clostridium perfringens strains. PLoS One4,e5598 (2009).
  MedlineGoogle Scholar
• 11  Katayama S, Dupuy B, Cole ST: Rapid expansion of the physical and genetic map of the chromosome of Clostridium perfringens CPN50. J. Bacteriol.177,5680–5685 (1995).
  Medline CASGoogle Scholar
• 12  Tweten RK: Nucleotide sequence of the gene for perfringolysin O (θ toxin) from Clostridium perfringens: significant homology with the genes for streptolysin and pneumolysin. Infect. Immun.56,3235–3240 (1988).
  Medline CASGoogle Scholar
• 13  Alouf J: Cholesterol binding toxins (Streptococcus, Bacillus, Clostridium, Listeria). In: Guidebook to Protein Toxins and their Use in Cell Biology. Rappuoli R, Montecucco C (Eds). Sambrook & Tooze Publications, Oxford, UK, 7–10 (1997).
  Google Scholar
• 14  Alouf JE: Molecular features of the cytolytic pore forming bacterial protein toxins. Folia Microbiol. (Praha)48,5–16 (2003).
  Medline CASGoogle Scholar
• 15  Tweten RK: Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun.73,6199–6209 (2005).
  Medline CASGoogle Scholar
• 16  Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW: Structure of a cholesterol-binding thiol-activated cytolysin and a model of its membrane form. Cell89,685–692 (1997).
  Medline CASGoogle Scholar
• 17  Soltani CE, Hotze EM, Johnson AE, Tweten RK: Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc. Natl Acad. Sci. USA104,20226–20231 (2007).
  Medline CASGoogle Scholar
• 18  Soltani CE, Hotze EM, Johnson AE, Tweten RK: Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J. Biol. Chem.282,15709–15716 (2007).
  Medline CASGoogle Scholar
• 19  Sekino-Suzuki N, Nakamura M, Mitsui K, Ohno-Iwashita O: Contribution of individual tryptophan residues to the structure and activity of θ-toxin (pefringolysin O), a cholesterol-binding cytolysin. Eur. J. Biochem.241,941–947 (1996).
  Medline CASGoogle Scholar
• 20  Waheed AA, Shimada Y, Heijnen HFG et al.: Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl Acad. Sci. USA98,4926–4931 (2001).
  Medline CASGoogle Scholar
• 21  Shepard L, Shatursky O, Johnson A, Tweten R: The mechanism of pore assembly for a cholesterol-dependent cytolysin: formation of a large prepore complex precedes the insertion of the transmembrane β-hairpins. Biochemistry39,10284–10293 (2000).
  Medline CASGoogle Scholar
• 22  Dang TX, Hotze EM, Rouiller I, Tweten RK, Wilson-Kubalek EM: Prepore to pore transition of a cholesterol-dependent cytolysin visualized by electron microscopy. J. Struct. Biol.150,100–108 (2005).
  Medline CASGoogle Scholar
• 23  Ramachandran R, Tweten RK, Johnson AE: Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit β-strand alignment. Nat. Struct. Mol. Biol.11,697–705 (2004).
  Medline CASGoogle Scholar
• 24  Heuck AP, Savva CG, Holzenburg A, Johnson AE: Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol. J. Biol. Chem.282,22629–22637 (2007).
  Medline CASGoogle Scholar
• 25  Rossjohn J, Polekhina G, Feil SC, Morton CJ, Tweten RK, Parker MW: Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J. Mol. Biol.367,1227–1236 (2007).
  Medline CASGoogle Scholar
• 26  Ramachandran R, Heuck AP, Tweten RK, Johnson AE: Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat. Struct. Biol.9,823–827 (2002).
  Medline CASGoogle Scholar
• 27  Heuck AP, Hotze EM, Tweten RK, Johnson AE: Mechanism of membrane insertion of a multimeric β-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell6,1233–1242 (2000).
  Medline CASGoogle Scholar
• 28  Heuck AP, Tweten RK, Johnson AE: β-barrel pore-forming toxins: intriguing dimorphic proteins. Biochemistry40,9065–9073 (2001).
  Medline CASGoogle Scholar
• 29  Shatursky O, Heuck A, Shepard L et al.: The mechanism of membrane insertion of a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell99,293–299 (1999).
  Medline CASGoogle Scholar
• 30  Hotze EM, Heuck AP, Czajkowsky DM, Shao Z, Johnson AE, Tweten RK: Monomer–monomer interactions drive the prepore to pore conversion of a β-barrel-forming cholesterol-dependent cytolysin. J. Biol. Chem.277,11597–11605 (2002).
  Medline CASGoogle Scholar
• 31  Czajkowsky DM, Hotze EM, Shao Z, Tweten RK: Vertical collapse of a cytolysin prepore moves its transmembrane β-hairpins to the membrane. EMBO J.23,3206–3215 (2004).
  Medline CASGoogle Scholar
• 32  Nelson LD, Johnson AE, London E: How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction. J. Biol. Chem.283,4632–4642 (2008).
  Medline CASGoogle Scholar
• 33  Stevens DL, Tweten RK, Awad MM, Rood JI, Bryant AE: Clostridial gas gangrene: evidence that α and τ-toxin differentially modulate the immune response and induce acute tissue necrosis. J. Infect. Dis.176,189–195 (1997).
  Medline CASGoogle Scholar
• 34  Bryant AE, Bergstrom R, Zimmerman GA et al.: Clostridium perfringens invasiveness is enhanced by effects of θ toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol. Med. Microbiol.7,321–326 (1993).
  Medline CASGoogle Scholar
• 35  Bryant AE, Stevens DL: Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis on cultured human umbilical vein endothelial cells. Infect. Immun.64,358–362 (1996).
  Medline CASGoogle Scholar
• 36  Awad MM, Ellenor DM, Bod RL, Emmins JJ, Rood JI: Synergistic effects of α-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun.69,7904–7910 (2001).
  Medline CASGoogle Scholar
• 37  Stevens DL, Bryant AE: The role of clostridial toxins in the pathogenesis of gas gangrene. Clin. Infect. Dis.35,S93–S100 (2002).
  Medline CASGoogle Scholar
• 38  Sayeed S, Fernandez-Miyakawa ME, Fisher DJ et al.: E-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect. Immun.73,7413–7421 (2005).
  Medline CASGoogle Scholar
• 39  Fernandez Miyakawa ME, Uzal FA: The early effects of Clostridium perfringens type D ε toxin in ligated intestinal loops of goats and sheep. Vet. Res. Commun.27,231–241 (2003).
  Medline CASGoogle Scholar
• 40  Losada-Eaton DM, Uzal FA, Fernandez Miyakawa ME: Clostridium perfringens ε toxin is absorbed from different intestinal segments of mice. Toxicon51,1207–1213 (2008).
  Medline CASGoogle Scholar
• 41  Tamai E, Ishida T, Miyata S et al.: Accumulation of Clostridium perfringens ε-toxin in the mouse kidney and its possible biological significance. Infect. Immun.71,5371–5375 (2003).
  Medline CASGoogle Scholar
• 42  Uzal FA, Songer JG: Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest.20,253–265 (2008).
  MedlineGoogle Scholar
• 43  Nagahama M, Sakurai J: Distribution of labeled Clostridium perfringens ε toxin in mice. Toxicon29,211–217 (1991).
  Medline CASGoogle Scholar
• 44  Nagahama M, Sakurai J: High-affinity binding of Clostridium perfringens ε-toxin to rat brain. Infect. Immun.60,1237–1240 (1992).
  Medline CASGoogle Scholar
• 45  Finnie JW: Neurological disorders produced by Clostridium perfringens type D ε toxin. Anaerobe10,145–150 (2004).
  Medline CASGoogle Scholar
• 46  Soler-Jover A, Dorca J, Popoff MR et al.: Distribution of Clostridium perfringens ε toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon50,530–540 (2007).
  Medline CASGoogle Scholar
• 47  Dorca-Arevalo J, Soler-Jover A, Gibert M, Popoff MR, Martin-Satue M, Blasi J: Binding of ε-toxin from Clostridium perfringens in the nervous system. Vet. Microbiol.131,14–25 (2008).
  Medline CASGoogle Scholar
• 48  Finnie JW: Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D ε toxin: a review. Aust. Vet. J.81,219–221 (2003).
  Medline CASGoogle Scholar
• 49  Miyamoto O, Minami J, Toyoshima T et al.: Neurotoxicity of Clostridium perfringens ε-toxin for the rat hipocampus via glutamanergic system. Infect. Immun.66,2501–2508 (1998).
  Medline CASGoogle Scholar
• 50  Hunter SE, Clarke IN, Kelly DC, Titball RW: Cloning and nucleotide sequencing of the Clostridium perfringens ε-toxin gene and its expression in Escherichia coli.Infect. Immun.60,102–110 (1992).
  Medline CASGoogle Scholar
• 51  Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A: λ-toxin of Clostridium perfringens activates the precursor of ε-toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol.41,527–535 (1997).
  Medline CASGoogle Scholar
• 52  Cole A: Structural studies on ε toxin from Clostridium perfringens. In: Protein Toxins of the Genus Clostridium and Vaccination. Duchesnes C, Mainil J, Popoff MR, Titball R (Eds). Presses de la Faculté de Médecine Vétérinaire, Liège, Belgium, 95 (2003).
  Google Scholar
• 53  Sakurai J: Toxins of Clostridium perfringens.Rev. Med. Microbiol.6,175–185 (1995).
  Google Scholar
• 54  Oyston PCF, Payne DW, Havard HL, Williamson ED, Titball RW: Production of a non-toxic site-directed mutant of Clostridium perfringens ε-toxin which induces protective immunity in mice. Microbiology144,333–341 (1998).
  Medline CASGoogle Scholar
• 55  Heine K, Pust S, Enzenmuller S, Barth H: ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death. Infect. Immun.76,4600–4608 (2008).
  Medline CASGoogle Scholar
• 56  Lindsay CD, Hambrook JL, Upshall DG: Examination of toxicity of Clostridium perfringens ε-toxin in the MDCK cell line. Toxicol. In Vitro9,213–218 (1995).
  Medline CASGoogle Scholar
• 57  Payne DW, Williamson ED, Havard H, Modi N, Brown J: Evaluation of a new cytotoxicity assay for Clostridium perfringens type D ε toxin. FEMS Microbiol. Lett.116,161–168 (1994).
  Medline CASGoogle Scholar
• 58  Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR: Clostridium perfringens ε-toxin acts on MDCK cells by forming a large membrane complex. J. Bacteriol.179,6480–6487 (1997).
  Medline CASGoogle Scholar
• 59  Shortt SJ, Titball RW, Lindsay CD: An assessment of the in vitro toxicology of Clostridium perfringens type D ε-toxin in human and animal cells. Hum. Exp. Toxicol.19,108–116 (2000).
  Medline CASGoogle Scholar
• 60  Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, Okabe A: Cleavage of C-terminal peptide is essential for heptamerization of Clostridium perfringens ε-toxin in the synaptosomal membrane. J. Biol. Chem.276,13778–13783 (2001).
  Medline CASGoogle Scholar
• 61  Miyata S, Minami J, Tamai E, Matsushita O, Shimamoto S, Okabe A: Clostridium perfringens ε-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin–Darby canine kidney cells and rat synaptosomes. J. Biol. Chem.277,39463–39468 (2002).
  Medline CASGoogle Scholar
• 62  Payne D, Williamson ED, Titball RW: The Clostridium perfringens ε-toxin. Rev. Med. Microbiol.8,S28–S30 (1997).
  Google Scholar
• 63  Chassin C, Bens M, de Barry J et al.: Pore-forming ε toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am. J. Physiol. Renal Physiol.293,F927–F937 (2007).
  Medline CASGoogle Scholar
• 64  Shimamoto S, Tamai E, Matsushita O, Minami J, Okabe A, Miyata S: Changes in ganglioside content affect the binding of Clostridium perfringens ε-toxin to detergent-resistant membranes of Madin–Darby canine kidney cells. Microbiol. Immunol.49,245–253 (2005).
  Medline CASGoogle Scholar
• 65  Nagahama M, Hara H, Fernandez-Miyakawa M, Itohayashi Y, Sakurai J: Oligomerization of Clostridium perfringens ε-toxin is dependent upon membrane fluidity in liposomes. Biochemistry45,296–302 (2006).
  Medline CASGoogle Scholar
• 66  Petit L, Maier E, Gibert M, Popoff MR, Benz R: Clostridium perfringens ε-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers. J. Biol. Chem.276,15736–15740 (2001).
  Medline CASGoogle Scholar
• 67  Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, Popoff MR: Clostridium perfringens ε toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell. Microbiol.5,155–164 (2003).
  Medline CASGoogle Scholar
• 68  Buxton D: The use of an imunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type D ε-toxin in mice. J. Med. Microbiol.11,289–292 (1978).
  Medline CASGoogle Scholar
• 69  Finnie JW, Blumbergs PC, Manavis J: Neuronal damage produced in rat brains by Clostridium perfringens type D ε-toxin. J. Comp. Path.120,415–420 (1999).
  Medline CASGoogle Scholar
• 70  Zhu C, Ghabriel MN, Blumbergs PC et al.: Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood brain barrier (BBB). Exp. Neurol.169,72–82 (2001).
  Medline CASGoogle Scholar
• 71  Miyamoto O, Sumitami K, Nakamura T et al.: Clostridium perfringens ε toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett.189,109–113 (2000).
  Medline CASGoogle Scholar
• 72  Kennedy CL, Krejany EO, Young LF et al.: The α-toxin of Clostridium septicum is essential for virulence. Mol. Microbiol.57,1357–1366 (2005).
  Medline CASGoogle Scholar
• 73  Melton JA, Parker MW, Rossjohn J, Buckley JT, Tweten RK: The identification and structure of the membrane-spanning domain of the Clostridium septicum α toxin. J. Biol. Chem.279,14315–14322 (2004).
  Medline CASGoogle Scholar
• 74  Imagawa T, Dohi Y, Higashi Y: Cloning, nucleotide sequence and expression of a hemolysin gene of Clostridium septicum. FEMS Microbiol. Lett.117,287–292 (1994).
  Medline CASGoogle Scholar
• 75  Ballard J, Crabtree J, Roe BA, Tweten RK: The primary structure of Clostridium septicum α-toxin exhibits similarity with that of Aeromonas hydrophila aerolysin. Infect. Immun.63,340–344 (1995).
  Medline CASGoogle Scholar
• 76  Ballard J, Bryant A, Stevens D, Tweten RK: Purification and characterization of the lethal toxin (α-toxin) of Clostridium septicum. Infect. Immun.60,784–790 (1992).
  Medline CASGoogle Scholar
• 77  Melton-Witt JA, Bentsen LM, Tweten RK: Identification of functional domains of Clostridium septicum α toxin. Biochemistry45,14347–14354 (2006).
  Medline CASGoogle Scholar
• 78  Amimoto K, Sasaki Y, Fukuyama S, Tamura Y: Genetic variation and cross-reactivity of Clostridium septicum α-toxin. Vet. Microbiol.114,51–59 (2006).
  Medline CASGoogle Scholar
• 79  Gordon VM, Benz R, Fujii K, Leppla SH, Tweten RK: Clostridium septicum α-toxin is proteolytically activated by furin. Infect. Immun.65,4130–4134 (1997).
  Medline CASGoogle Scholar
• 80  Ballard J, Sokolov Y, Yuan WL, Kagan BL, Tweten RK: Activation and mechanism of Clostridium septicum α toxin. Mol. Microbiol.10,627–634 (1993).
  Medline CASGoogle Scholar
• 81  Gordon VM, Nelson KL, Buckley JT et al.: Clostridium septicum α-toxin uses glycosylphosphatidylinositol-anchored protein receptors. J. Biol. Chem.274,27274–27280 (1999).
  Medline CASGoogle Scholar
• 82  Hong Y, Ohishi K, Inoue N et al.: Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum α-toxin. EMBO J.21,5047–5056 (2002).
  Medline CASGoogle Scholar
• 83  Hang’ombe MB, Mukamoto M, Kohda T, Sugimoto N, Kozaki S: Cytotoxicity of Clostridium septicum α-toxin: its oligomerization in detergent resistant membranes of mammalian cells. Microb. Pathog.37,279–286 (2004).
  MedlineGoogle Scholar
• 84  Sellman BR, Tweten RK: The propeptide of Clostridium septicum α toxin functions as an intramolecular chaperone and is a potent inhibitor of α toxin-dependent cytolysis. Mol. Microbiol.25,429–440 (1997).
  Medline CASGoogle Scholar
• 85  Sellman BR, Kagan BL, Tweten RK: Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum α toxin. Mol. Microbiol.23,531–538 (1997).
  Google Scholar
• 86  Tweten RK: Clostridium perfringens β toxin and Clostridium septicum α toxin: their mechanisms and possible role in pathogenesis. Vet. Microbiol.82,1–9 (2001).
  Medline CASGoogle Scholar
• 87  Kennedy CL, Lyras D, Cordner LM et al.: Pore-forming activity of α-toxin is essential for clostridium septicum-mediated myonecrosis. Infect. Immun.77,943–951 (2009).
  Medline CASGoogle Scholar
• 88  Kennedy CL, Smith DJ, Lyras D, Chakravorty A, Rood JI: Programmed cellular necrosis mediated by the pore-forming α-toxin from Clostridium septicum. PLoS Pathog.5,e1000516 (2009).
  MedlineGoogle Scholar
• 89  Knapp O, Maier E, Ben Mkaddem S et al.: Clostridium septicum α-toxin forms pores and induces rapid cell necrosis. Toxicon. (2009) (Epub ahead of print).
  Google Scholar
• 90  Wichroski MJ, Melton JA, Donahue CG, Tweten RK, Ward GE: Clostridium septicum α-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins. Infect. Immun.70,4353–4361 (2002).
  Medline CASGoogle Scholar
• 91  Melton JA, Tweten RK: Clostridium septicum pore-forming α-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 623–630 (2006).
  Google Scholar
• 92  Lindsay JA: Clostridium perfringens type A enterotoxin (CPE): more than just explosive diarrhea. Crit. Rev. Microbiol.22,257–277 (1996).
  Medline CASGoogle Scholar
• 93  Petit L, Gibert M, Popoff MR: Clostridium perfringens enterotoxin and C. perfringens food poisoning. In: Encyclopedia of Food Microbiology. Robinson R, Batt C, Patel P (Eds). Academic Press, London, UK, 438–444 (1999).
  Google Scholar
• 94  Brynestad S, Sarker MR, McClane BA, Granum PE, Rood JI: The enterotoxin (CPE) plasmid from Clostridium perfringens is conjugative. Infect. Immun.69,3483–3487 (2001).
  Medline CASGoogle Scholar
• 95  Brynestad S, Synstad B, Granum PE: The Clostridium perfringens enterotoxin gene is on a transposable element in type A human food poisoning strains. Microbiology143,2109–2115 (1997).
  Medline CASGoogle Scholar
• 96  Cornillot E, Saint-Joanis B, Daube G, Granum PE, Canard B, Cole ST: The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol. Microbiol.15,639–647 (1995).
  Medline CASGoogle Scholar
• 97  Sparks SG, Carman RJ, Sarker MR, McClane BA: Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America. J. Clin. Microbiol.39,883–888 (2001).
  Medline CASGoogle Scholar
• 98  Collie RE, McClane BA: Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases. J. Clin. Microbiol.36,30–36 (1998).
  Medline CASGoogle Scholar
• 99  Miyamoto K, Fisher DJ, Li J, Sayeed S, Akimoto S, McClane BA: Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. J. Bacteriol.188,1585–1598 (2006).
  Medline CASGoogle Scholar
• 100  Kobayashi S, Wada A, Shibasaki S et al.: Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a geriatric hospital. Epidemiol. Infect.137,108–113 (2009).
  Medline CASGoogle Scholar
• 101  Li J, McClane BA: Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl. Environ. Microbiol.72,4561–4568 (2006).
  Medline CASGoogle Scholar
• 102  Li J, McClane BA: Comparative effects of osmotic, sodium nitrite-induced, and pH-induced stress on growth and survival of Clostridium perfringens type A isolates carrying chromosomal or plasmid-borne enterotoxin genes. Appl. Environ. Microbiol.72,7620–7625 (2006).
  Medline CASGoogle Scholar
• 103  Lahti P, Heikinheimo A, Johansson T, Korkeala H: Clostridium perfringens type A strains carrying a plasmid-borne enterotoxin gene (genotype IS1151-cpe or IS1470-like-cpe) as a common cause of food poisoning. J. Clin. Microbiol.46,371–373 (2008).
  MedlineGoogle Scholar
• 104  Tanaka D, Kimata K, Shimizu M et al.: Genotyping of Clostridium perfringens isolates collected from food poisoning outbreaks and healthy individuals in Japan based on the cpe locus. Jpn. J. Infect. Dis.60,68–69 (2007).
  MedlineGoogle Scholar
• 105  Nakamura M, Kato A, Tanaka D et al.: PCR identification of the plasmid-borne enterotoxin gene (cpe) in Clostridium perfringens strains isolated from food poisoning outbreaks. Int. J. Med. Microbiol.294,261–265 (2004).
  Medline CASGoogle Scholar
• 106  Kokai-Kun JF, McClane BA: Deletion analysis of the Clostridium perfringens enterotoxin. Infect. Immun.65,1014–1022 (1997).
  Medline CASGoogle Scholar
• 107  Hanna PC, Mietzner TA, Schoolnik GK, McClane BA: Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J. Biol. Chem.266,11037–11043 (1991).
  Medline CASGoogle Scholar
• 108  Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S: Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett.476,258–261 (2000).
  Medline CASGoogle Scholar
• 109  Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N: Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol.136,1239–1247 (1997).
  Medline CASGoogle Scholar
• 110  Sonoda N, Furuse M, Sasaki H et al.: Clostridium perfringens enterotoxin fragment removes specific claudin from tight junction strands: evidence for direct involvement of claudin in tight junction barrier. J. Cell Biol.147,195–204 (1999).
  MedlineGoogle Scholar
• 111  Winkler L, Gehring C, Wenzel A et al.: Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J. Biol. Chem.284,18863–18872 (2009).
  Medline CASGoogle Scholar
• 112  Van Itallie CM, Betts L, Smedley JG 3rd, McClane BA, Anderson JM: Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem.283,268–274 (2008).
  Medline CASGoogle Scholar
• 113  Caserta JA, Hale ML, Popoff MR, Stiles BG, McClane BA: Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin. Infect. Immun.76,5677–5685 (2008).
  Medline CASGoogle Scholar
• 114  Wieckowski EU, Kokai-Kun JF, McClane BA: Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment. Infect. Immun.66,5897–5905 (1998).
  Medline CASGoogle Scholar
• 115  Singh U, Van Itallie CM, Mitic LL, Anderson JM, McClane BA: CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple complex species, one of which contains the tight junction protein occludin. J. Biol. Chem.275,18407–18417 (2000).
  Medline CASGoogle Scholar
• 116  Smedley JG 3rd, Uzal FA, McClane BA: Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun.75,2381–2390 (2007).
  Medline CASGoogle Scholar
• 117  Singh U, Mitic LL, Wieckowski EU, Anderson JM, McClane BA: Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. J. Biol. Chem.276,33402–33412 (2001).
  Medline CASGoogle Scholar
• 118  Chakrabarti G, McClane BA: The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol.7,129–146 (2005).
  Medline CASGoogle Scholar
• 119  McClane BA: An overview of Clostridium perfringens enterotoxin. Toxicon34,1335–1343 (1996).
  Medline CASGoogle Scholar
• 120  Smedley JG 3rd, Saputo J, Parker JC et al.: Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun.76,3793–3800 (2008).
  Medline CASGoogle Scholar
• 121  Fernandez Miyakawa ME, Pistone Creydt V, Uzal FA, McClane BA, Ibarra C: Clostridium perfringens enterotoxin damages the human intestine in vitro.Infect. Immun.73,8407–8410 (2005).
  Medline CASGoogle Scholar
• 122  Sayeed S, Uzal FA, Fisher DJ et al.: β toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol.67,15–30 (2008).
  Medline CASGoogle Scholar
• 123  Fernandez-Miyakawa ME, Fisher DJ, Poon R et al.: Both ε-toxin and β-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Infect. Immun.75,1443–1452 (2007).
  Medline CASGoogle Scholar
• 124  Fisher DJ, Fernandez-Miyakawa ME, Sayeed S et al.: Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun.74,5200–5210 (2006).
  Medline CASGoogle Scholar
• 125  Vidal JE, McClane BA, Saputo J, Parker J, Uzal FA: Effects of Clostridium perfringens β-toxin on the rabbit small intestine and colon. Infect. Immun.76,4396–4404 (2008).
  Medline CASGoogle Scholar
• 126  Hunter SE, Brown E, Oyston PCF, Sakurai J, Titball RW: Molecular genetic analysis of β-toxin of Clostridium perfringens reveals sequence homology with α-toxin, γ-toxin, and leukocidin of Staphylococcus aureus.Infect. Immun.61,3958–3965 (1993).
  MedlineGoogle Scholar
• 127  Gibert M, Perelle S, Daube G, Popoff MR: Clostridium spiroforme toxin genes are related to C. perfringens ι toxin genes but have a different genomic localization. Syst. Appl. Microbiol.20,337–347 (1997).
  CASGoogle Scholar
• 128  Katayama S, Dupuy B, Daube G, China B, Cole S: Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plamsid-borne. Mol. Gen. Genet.251,720–726 (1996).
  Medline CASGoogle Scholar
• 129  Sakurai J, Fujii Y, Matsuura M: Effect of oxidizing agents and sulfhydryl group reagents on β toxin from Clostridium perfringens type C. Microbiol. Immunol.24,595–601 (1980).
  Medline CASGoogle Scholar
• 130  Nagahama M, Miyawaki T, Kihara A et al.: Thiol group reagent-sensitive Clostridium perfringens β-toxin does not require a thiol group for lethal activity. Biochim. Biophys. Acta1454,97–105 (1999).
  Medline CASGoogle Scholar
• 131  Steinthorsdottir V, Fridiksdottir V, Gunnarson E, Andresson O: Site-directed mutagenesis of Clostridium perfringens β-toxin expression of wild type and mutant toxins in Bacillus subtilis.FEMS Microbiol. Lett.158,17–23 (1998).
  Medline CASGoogle Scholar
• 132  Steinthorsdottir V, Halldorson H, Andresson O: Clostridium perfringens β-toxin forms multimeric transmembrane pores in human endothelial cells. Microb. Pathog.28,45–50 (2000).
  Medline CASGoogle Scholar
• 133  Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK: Clostridium perfringens β-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect. Immun.68,5546–5551 (2000).
  Medline CASGoogle Scholar
• 134  Nagahama M, Hayashi H, Morimitsu S, Sakurai J: Biological activities and pore formation of Clostridium perfringens β toxin in HL60 cells. J. Biol. Chem.278,36934–36941 (2003).
  Medline CASGoogle Scholar
• 135  Nagahama M, Morimitsu S, Kihara A, Akita M, Setsu K, Sakurai J: Involvement of tachykinin receptors in Clostridium perfringens β-toxin-induced plasma extravasation. Br. J. Pharmacol.138,23–30 (2003).
  Medline CASGoogle Scholar
• 136  Nagahama M, Kihara A, Kintoh H, Oda M, Sakurai J: Involvement of tumour necrosis factor-α in Clostridium perfringens β-toxin-induced plasma extravasation in mice. Br. J. Pharmacol.153,1296–1302 (2008).
  Medline CASGoogle Scholar
• 137  Gibert M, Jolivet-Reynaud C, Popoff MR: β2 toxin, a novel toxin produced by Clostridium perfringens.Gene203,65–73 (1997).
  Medline CASGoogle Scholar
• 138  Herholz C, Miserez R, Nicolet J et al.: Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders. J. Clin. Microbiol.37,358–361 (1999).
  Medline CASGoogle Scholar
• 139  Vilei EM, Schlatter Y, Perreten V et al.: Antibiotic-induced expression of a cryptic cpb2 gene in equine β2-toxigenic Clostridium perfringens.Mol. Microbiol.57,1570–1581 (2005).
  Medline CASGoogle Scholar
• 140  Waters M, Raju D, Garmory HS, Popoff MR, Sarker MR: Regulated expression of the β2-toxin gene (cpb2) in Clostridium perfringens type a isolates from horses with gastrointestinal diseases. J. Clin. Microbiol.43,4002–4009 (2005).
  Medline CASGoogle Scholar
• 141  Bacciarini LN, Boerlin P, Straub R, Frey J, Grone A: Immunohistochemical localization of Clostridium perfringens β2-toxin in the gastrointestinal tract of horses. Vet. Pathol.40,376–381 (2003).
  Medline CASGoogle Scholar
• 142  van Asten AJ, Nikolaou GN, Grone A: The occurrence of cpb2-toxigenic Clostridium perfringens and the possible role of the β2-toxin in enteric disease of domestic animals, wild animals and humans. Vet. J. (2008) (Epub ahead of print).
  MedlineGoogle Scholar
• 143  Lebrun M, Filee P, Mousset B et al.: The expression of Clostridium perfringens consensus β2 toxin is associated with bovine enterotoxaemia syndrome. Vet. Microbiol.120,151–157 (2007).
  Medline CASGoogle Scholar
• 144  Harrison B, Raju D, Garmory HS, Brett MM, Titball RW, Sarker MR: Molecular characterization of Clostridium perfringens isolates from humans with sporadic diarrhea: evidence for transcriptional regulation of the β2-toxin-encoding gene. Appl. Environ. Microbiol.71,8362–8370 (2005).
  Medline CASGoogle Scholar
• 145  Fisher DJ, Miyamoto K, Harrison B, Akimoto S, Sarker MR, McClane BA: Association of β2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol.56,747–762 (2005).
  Medline CASGoogle Scholar
• 146  Waters M, Savoie A, Garmory HS et al.: Genotyping and phenotyping of β2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J. Clin. Microbiol.41,3584–3591 (2003).
  Medline CASGoogle Scholar
• 147  Jolivet-Reynaud C, Popoff MR, Vinit MA, Ravisse P, Moreau H, Alouf JE: Enteropathogenicity of Clostridium perfringens β toxin and other clostridial toxins. Zentralbl. Bakteriol.S15,145–151 (1986).
  Google Scholar
• 148  Keyburn AL, Boyce JD, Vaz P et al.: NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens.PLoS Pathog.4,e26 (2008).
  MedlineGoogle Scholar
• 149  Manich M, Knapp O, Gibert M et al.: Clostridium perfringens δ toxin is sequence related to β toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences. PLoS ONE3,e3764 (2008).
  MedlineGoogle Scholar
• 150  Chalmers G, Bruce HL, Hunter DB et al.: Multilocus sequence typing analysis of Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler chicken populations. J. Clin. Microbiol.46,3957–3964 (2008).
  Medline CASGoogle Scholar
• 151  Truscott RB, Al-Sheikhly F: Reproduction and treatment of necrotic enteritis in broilers. Am. J. Vet. Res.38,857–861 (1977).
  Medline CASGoogle Scholar
• 152  Al-Sheikhly F, Truscott RB: The interaction of Clostridium perfringens and its toxins in the production of necrotic enteritis of chickens. Avian Dis.21,256–263 (1977).
  Medline CASGoogle Scholar
• 153  Keyburn AL, Sheedy SA, Ford ME et al.: α-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect. Immun.74,6496–6500 (2006).
  Medline CASGoogle Scholar
• 154  Jolivet-Reynaud C, Launay JM, Alouf JE: Damaging effects of Clostridium perfringens δ toxin on blood platelets and their relevance to ganglioside G_M2. Arch. Biochem. Biophys.262,59–66 (1988).
  Medline CASGoogle Scholar
• 155  Jolivet C, Alouf JE: Binding of Clostridium perfringens¹²⁵I-labeled δ-toxin to erythrocytes. J. Biol. Chem.258,1871–1877 (1983).
  MedlineGoogle Scholar
• 156  Jolivet-Reynaud C, Hauttecoeur B, Alouf J: Interaction of Clostridium perfringens δ-toxin with erythrocyte and liposome membranes and relation with the specific binding to the ganglioside G_M2. Toxicon27,1113–1126 (1989).
  Medline CASGoogle Scholar
• 157  Stevens DL, Troyer BE, Merrick DT, Mitten JE, Olson RD: Lethal effects and cardiovascular effects of purified α- and τ-toxins from Clostridium perfringens.J. Infect. Dis.157,272–279 (1988).
  Medline CASGoogle Scholar
• 158  Flores-Diaz M, Alape-Giron A: Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene. Toxicon42,979–986 (2003).
  Medline CASGoogle Scholar
• 159  Shimizu-Reynaud T, Ohtani K, Ba-Thein W, Inui S, Nakamura S, Hayashi H: Characterization of α toxin-deficient Clostridium perfringens strain, KZ1340. Microbiol. Immunol.40,141–145 (1996).
  MedlineGoogle Scholar
• 160  Brett MM: Outbreaks of food-poisoning associated with lecithinase-negative Clostridium perfringens.J. Med. Microbiol.41,405–407 (1994).
  Medline CASGoogle Scholar
• 161  Justin N, Walker N, Bullifent HL et al.: The first strain of Clostridium perfringens isolated from an avian source has an α-toxin with divergent structural and kinetics properties. Biochemistry41,6253–6262 (2002).
  Medline CASGoogle Scholar
• 162  Abildgaard L, Engberg RM, Pedersen K, Schramm A, Hojberg O: Sequence variation in the α-toxin encoding plc gene of Clostridium perfringens strains isolated from diseased and healthy chickens. Vet. Microbiol.136,293–299 (2008).
  MedlineGoogle Scholar
• 163  Sheedy SA, Ingham AB, Rood JI, Moore RJ: Highly conserved α-toxin sequences of avian isolates of Clostridium perfringens.J. Clin. Microbiol.42,1345–1347 (2004).
  Medline CASGoogle Scholar
• 164  Naylor CE, Eaton JT, Howells A et al.: Structure of the key toxin in gas gangrene. Nat. Struct. Biol.5,738–746 (1998).
  Medline CASGoogle Scholar
• 165  Titball RW, Leslie DL, Harvey S, Kelly D: Hemolytic and sphingomyelinase activities of Clostridium perfringens α-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect. Immun.59,1872–1874 (1991).
  Medline CASGoogle Scholar
• 166  Guillouard I, Garnier T, Cole S: Use of site-directed mutagenesis to probe structure–function relationship of α-toxin from Clostridium perfringens.Infect. Immun.64,2440–2444 (1996).
  Medline CASGoogle Scholar
• 167  Nagahama M, Nakayama T, Michiue K, Sakurai J: Site-specific mutagenesis of Clostridium perfringens α-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activites. Infect. Immun.65,3489–3492 (1997).
  Medline CASGoogle Scholar
• 168  Nagahama MY, Okagawa T, Nakayama T, Nishioka E, Sakurai J: Site directed mutagenesis of histidine residues in Clostridium perfringens α-toxin. J. Bacteriol.177,1179–1185 (1995).
  Medline CASGoogle Scholar
• 169  Eaton JT, Naylor CE, Howells AM, Moss DS, Titball RW, Basak AK: Crystal structure of the C. perfringens α-toxin with the active site closed by a flexible loop region. J. Mol. Biol.319,275–281 (2002).
  Medline CASGoogle Scholar
• 170  Titball RW: Biochemical and immunological properties of the C-terminal domain of the α-toxin of Clostridium perfringens.FEMS Microbiol. Lett.110,45–50 (1993).
  Medline CASGoogle Scholar
• 171  Nagahama M, Mukai M, Morimitsu S, Ochi S, Sakurai J: Role of the C-domain in the biological activities of Clostridium perfringens α-toxin. Microbiol. Immunol.46,647–655 (2002).
  Medline CASGoogle Scholar
• 172  Moreau H, Pieroni G, Jolivet-Reynaud C, Alouf JE, Verger R: A new kinetic approach for studying phospholipase C (Clostridium perfringens α toxin) activity on phospholipid monolayers. Biochemistry27,2319–2323 (1988).
  Medline CASGoogle Scholar
• 173  Nagahama M, Michiue K, Mukai M, Ochi S, Sakurai J: Mechanism of membrane damage by Clostridium perfringens α-toxin. Microbiol. Immunol.42,533–538 (1998).
  Medline CASGoogle Scholar
• 174  Jepson M, Howells A, Bullifent HL et al.: Differences in the carboxy-terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes. Infect. Immun.67,3297–3301 (1999).
  Medline CASGoogle Scholar
• 175  Guillouard I, Alzari PM, Saliou B, Cole ST: The carboxy-terminal C2-like domain of the α-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition. Mol. Microbiol.26,867–876 (1997).
  Medline CASGoogle Scholar
• 176  Williamson ED, Titball RW: A genetically engineered vaccine against the α-toxin of Clostridium perfringens also protects mice against experimental gas gangrene. Vaccine11,1253–1258 (1993).
  Medline CASGoogle Scholar
• 177  Titball RW, Naylor CE, Basak AK: The Clostridium perfringens α-toxin. Anaerobe5,51–64 (1999).
  Medline CASGoogle Scholar
• 178  Nagahama M, Michiue K, Sakurai J: Membrane-damaging action of Clostridium perfringens α-toxin on phospholipid liposomes. Biochim. Biophys. Acta1280,120–126 (1996).
  MedlineGoogle Scholar
• 179  Nagahama M, Otsuka A, Oda M et al.: Effect of unsaturated bonds in the sn-2 acyl chain of phosphatidylcholine on the membrane-damaging action of Clostridium perfringens α-toxin toward liposomes. Biochim. Biophys. Acta1768,2940–2945 (2007).
  Medline CASGoogle Scholar
• 180  Sakurai J, Ochi S, Tanaka H: Evidence for coupling of Clostridium perfringens α-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes. Infect. Immun.61,3711–3718 (1993).
  Medline CASGoogle Scholar
• 181  Ochi S, Hashimoto K, Nagahama M, Sakurai J: Phospholipid metabolism induced by Clostridium perfringens α-toxin elicits a hot cold type of hemolysis in rabbit erythrocytes. Infect. Immun.64,3930–3933 (1996).
  Medline CASGoogle Scholar
• 182  Oda M, Matsuno T, Shiihara R et al.: The relationship between the metabolism of sphingomyelin species and the hemolysis of sheep erythrocytes induced by Clostridium perfringens α-toxin. J. Lipid Res.49,1039–1047 (2008).
  Medline CASGoogle Scholar
• 183  Sakurai J, Nagahama M, Oda M: Clostridium perfringens α-toxin: characterization and mode of action. J. Biochem.136,569–574 (2004).
  Medline CASGoogle Scholar
• 184  Oda M, Ikari S, Matsuno T, Morimune Y, Nagahama M, Sakurai J: Signal transduction mechanism involved in Clostridium perfringens α-toxin-induced superoxide anion generation in rabbit neutrophils. Infect. Immun.74,2876–2886 (2006).
  Medline CASGoogle Scholar
• 185  O’Brien DK, Melville SB: Effects of Clostridium perfringens α-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect. Immun.72,5204–5215 (2004).
  MedlineGoogle Scholar
• 186  Bryant AE, Bayer CR, Hayes-Schroer SM, Stevens D: Activation of platelet gpIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry. J. Infect. Dis.187,408–417 (2003).
  Medline CASGoogle Scholar
• 187  Bryant AE, Chen RYZ, Nagata Y et al.: Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J. Infect. Dis.182,808–815 (2000).
  Medline CASGoogle Scholar
• 188  Bryant AE, Chen RYZ, Nagata Y et al.: Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens.J. Infect. Dis.182,799–807 (2000).
  Medline CASGoogle Scholar
• 189  Bunting M, Lorant DE, Bryant AE et al.: A toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J. Clin. Invest.100,565–574 (1997).
  Medline CASGoogle Scholar
• 190  Abe A, Matsuzawa T, Kuwae A: Type-III effectors: sophisticated bacterial virulence factors. C. R. Biol.328,413–428 (2005).
  Medline CASGoogle Scholar
• 191  Flores-Diaz M, Alape-Giron A, Titball RW et al.: UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J. Biol. Chem.273,24433–24438 (1998).
  Medline CASGoogle Scholar
• 192  Matsushita O, Jung CM, Katayama S, Minami J, Takahashi Y, Okabe A: Gene duplication and multiplicity of collagenases in Clostridium histolyticum.J. Bacteriol.181, 923–933 (1999).
  Google Scholar
• 193  Jung CM, Matsushita O, Katayama S, Minami J, Sakurai J, Okabe A: Identification of metal ligands in the Clostridium histolyticum ColH collagenase. J. Bacteriol.181,2816–2822 (1999).
  Medline CASGoogle Scholar
• 194  Matsushita O, Jung CM, Minami J, Katayama S, Nishi N, Okabe A: A study of the collagen-binding domain of a 116 kDa Clostridium histolyticum collagenase. J. Biol. Chem.273,3643–3648 (1998).
  Medline CASGoogle Scholar
• 195  Matsushita O, Okabe A: Clostridial hydrolytic enzymes degrading extracellular components. Toxicon39,1769–1780 (2001).
  Medline CASGoogle Scholar
• 196  Wilson JJ, Matsushita O, Okabe A, Sakon J: A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation. EMBO J.22,1743–1752 (2003).
  Medline CASGoogle Scholar
• 197  Matsushita O, Yoshihara K, Katayama S, Minami J, Okabe A: Purification and characterization of a Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene. J. Bacteriol.176,149–156 (1994).
  Medline CASGoogle Scholar
• 198  Awad MM, Ellemor DM, Bryant AE et al.: Construction and virulence testing of a collagenase mutant of Clostridium perfringens.Microb. Pathog.28,107–117 (2000).
  Medline CASGoogle Scholar
• 199  Okumura K, Ohtani K, Hayashi H, Shimizu T: Characterization of genes regulated directly by the VirR/VirS system in Clostridium perfringens.J. Bacteriol.190,7719–7727 (2008).
  Medline CASGoogle Scholar
• 200  Petit L, Gibert M, Popoff MR: Clostridium perfringens: toxinotype and genotype. Trends Microbiol.7,104–110 (1999).
  Medline CASGoogle Scholar
• 201  Popoff MR: Molecular biology of actin-ADP-ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 275–302 (2000).
  Google Scholar
• 202  Barth H, Aktories K, Popoff MR, Stiles BG: Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev.68,373–402 (2004).
  Medline CASGoogle Scholar
• 203  Popoff MR, Stiles BG: Bacterial toxins and virulence factors targetting the actin cytoskeleton and intercellular junctions. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 154–187 (2006).
  Google Scholar
• 204  Gibert M, Petit L, Raffestin S, Okabe A, Popoff MR: Clostridium perfringens ι-toxin requires activation of both binding and enzymatic components for cytopathic activity. Infect. Immun.68,3848–3853 (2000).
  Medline CASGoogle Scholar
• 205  Ohishi I: Structure and function of actin-adenosine-diphosphate-ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 253–273 (2000).
  Google Scholar
• 206  Petosa C, Collier JR, Klimpel KR, Leppla SH, Liddington RC: Crystal structure of the anthrax toxin protective antigen. Nature385,833–838 (1997).
  Medline CASGoogle Scholar
• 207  Cunningham K, Lacy DB, Mogridge J, Collier RJ: Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl Acad. Sci. USA99,7049–7053 (2002).
  Medline CASGoogle Scholar
• 208  Abrami L, Liu S, Cosson P, Leppla SH, van der Goot FG: Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol.160,321–328 (2003).
  Medline CASGoogle Scholar
• 209  Mogridge J, Cuningham K, Lacy DB, Mourez M, Collier RJ: The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc. Natl Acad. Sci. USA99,7045–7048 (2002).
  Medline CASGoogle Scholar
• 210  Mogridge J, Cunningham K, Collier RJ: Stoichiometry of anthrax toxin complexes. Biochemistry41,1079–1082 (2002).
  Medline CASGoogle Scholar
• 211  Schleberger C, Hochmann H, Barth H, Aktories K, Schulz GE: Structure and action of the binary C2 toxin from Clostridium botulinum.J. Mol. Biol.364,705–715 (2006).
  Medline CASGoogle Scholar
• 212  Blöcker D, Barth H, Maier E, Benz R, Barbieri JT, Aktories K: The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding. Infect. Immun.68,4566–4573 (2000).
  Medline CASGoogle Scholar
• 213  Marvaud JC, Smith T, Hale ML, Popoff MR, Smith LA, Stiles BG: Clostridium perfringens ι-toxin: mapping of receptor binding and Ia docking domains on Ib. Infect. Immun.69,2435–2441 (2001).
  Medline CASGoogle Scholar
• 214  Stiles B, Hale ML, Marvaud JC, Popoff MR: Clostridium perfringens ι toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect. Immun.68,3475–3484 (2000).
  Medline CASGoogle Scholar
• 215  Eckhardt M, Barth H, Blöcker D, Aktories K: Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates. J. Biol. Chem.275,2328–2334 (2000).
  Medline CASGoogle Scholar
• 216  Barth H, Hofmann F, Olenik C, Just I, Aktories K: The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin. Infect. Immun.66,1364–1369 (1998).
  Medline CASGoogle Scholar
• 217  Han S, Craig JA, Putnam CD, Carozzi NB, Tainer JA: Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat. Struct. Biol.6,932–936 (1999).
  Medline CASGoogle Scholar
• 218  Tsuge H, Nagahama M, Nishimura H et al.: Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens ι-toxin. J. Mol. Biol.325,471–483 (2003).
  Medline CASGoogle Scholar
• 219  Marvaud JC, Stiles BG, Chenal A et al.: Clostridium perfringens ι toxin: mapping of the Ia domain involved in docking with Ib and cellular internalization. J. Biol. Chem.277,43659–43666 (2002).
  Medline CASGoogle Scholar
• 220  Barth H, Roebling R, Fritz M, Aktories K: The binary Clostridium botulinum C2 toxin as a protein delivery system. J. Biol. Chem.277,5074–5081 (2002).
  Medline CASGoogle Scholar
• 221  Tsuge H, Nagahama M, Oda M et al.: Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens ι-toxin. Proc. Natl Acad. Sci. USA105,7399–7404 (2008).
  Medline CASGoogle Scholar
• 222  Perelle S, Gibert M, Boquet P, Popoff MR: Characterization of Clostridium perfringens ι-toxin genes and expression in Escherichia coli. Infect. Immun.61,5147–5156 (Author’s correction: 63,4967 [1995]) (1993).
  Medline CASGoogle Scholar
• 223  Simpson LL, Stiles BG, Zepeda HH, Wilkins TD: Molecular basis for the pathological actions of Clostridium perfringens ι toxin. Infect. Immun.55,118–122 (1987).
  Medline CASGoogle Scholar
• 224  Bachmeyer C, Benz R, Barth H, Aktories K, Gibert M, Popoff MR: Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function in chloroquine and related compounds in vitro and toxin action in vivo.FASEB J.15,1658–1660 (2001).
  Medline CASGoogle Scholar
• 225  Barth H, Blöcker D, Behlke J et al.: Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J. Biol. Chem.275,18704–18711 (2000).
  Medline CASGoogle Scholar
• 226  Knapp O, Benz R, Gibert M, Marvaud JC, Popoff MR: Interaction of Clostridium perfringens ι-toxin with lipid bilayer membranes. J. Biol. Chem.277,6143–6152 (2002).
  Medline CASGoogle Scholar
• 227  Schmid A, Benz R, Just I, Aktories K: Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes. J. Biol. Chem.269,16706–16711 (1994).
  Medline CASGoogle Scholar
• 228  Gibert M, Marvaud JC, Pereira Y et al.: Differential requirement for the translocation of clostridial binary toxins: ι toxin requires a membrane potential gradient. FEBS Lett.581,1287–1296 (2007).
  Medline CASGoogle Scholar
• 229  Ohishi I: Activation of botulinum C2 toxin by trypsin. Infect. Immun.55,1461–1465 (1987).
  Medline CASGoogle Scholar
• 230  Stiles BG, Hale ML, Marvaud JC, Popoff MR: Clostridium perfringens ι toxin: characterization of the cell-asociated ι b complex. Biochem. J.367,801–808 (2002).
  Medline CASGoogle Scholar
• 231  Neumeyer T, Schiffler B, Maier E, Lang AE, Aktories K, Benz R: Clostridium botulinum C2 toxin. Identification of the binding site for chloroquine and related compounds and influence of the binding site on properties of the C2II channel. J. Biol. Chem.283,3904–3914 (2008).
  Medline CASGoogle Scholar
• 232  Lang AE, Neumeyer T, Sun J, Collier RJ, Benz R, Aktories K: Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxin. Biochemistry47,8406–8413 (2008).
  Medline CASGoogle Scholar
• 233  Kaiser E, Haug G, Hliscs M, Aktories K, Barth H: Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction. Biochemistry45,13361–13368 (2006).
  Medline CASGoogle Scholar
• 234  Haug G, Aktories K, Barth H: The host cell chaperone Hsp90 is necessary for cytotxic action of the binary ι-like toxins. Infect. Immun.72,3066–3068 (2004).
  Medline CASGoogle Scholar
• 235  Haug G, Leemhuis J, Tiemann D, Meyer DK, Aktories K, Barth H: The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. J. Biol. Chem.278,32266–32274 (2003).
  Medline CASGoogle Scholar
• 236  Ratts R, Zeng H, Berg EA et al.: The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J. Cell Biol.160,1139–1150 (2003).
  Medline CASGoogle Scholar
• 237  Richard JF, Mainguy G, Gibert M, Marvaud JC, Stiles BG, Popoff MR: Transcytosis of ι toxin across polarized CaCo-2 cell monolayers. Mol. Microbiol.43,907–917 (2002).
  Medline CASGoogle Scholar
• 238  Reuner KH, Dunker P, van der Does A et al.: Regulation of actin synthesis in rat hepatocytes by cytoskeleton rearrangements. Eur. J. Cell Biol.69,189–196 (1996).
  Medline CASGoogle Scholar
• 239  Kiefer G, Lerner M, Sehr P, Just I, Aktories K: Cytotoxic effects by microinjection of ADP-ribosylated skeletal muscle G-actin in PtK2 cells in the absence of Clostridium perfringens ι toxin. Med. Microbiol. Immunol.184,175–180 (1996).
  Medline CASGoogle Scholar
• 240  Uematsu Y, Kogo Y, Ohishi I: Disassembly of actin filaments by botulinum C2 toxin and actin-filament-disrupting agents induces assembly of microtubules in human leukaemia cell lines. Biol. Cell99,141–150 (2007).
  Medline CASGoogle Scholar
• 241  Barth H, Klinger M, Aktories K, Kinzel V: Clostridium botulinum C2 toxin delays entry into mitosis and activation of p34^cdc2 kinase and cdc25-C phosphatase in Hela cells. Infect. Immun.67,5083–5090 (1999).
  Medline CASGoogle Scholar
• 242  Vershueren H, van der Taelen I, Dewit J et al.: Effects of Clostridium botulinum C2 toxin and cytochalasin D on in vitro invasiveness, motility and F-actin content of a murine T-lymphoma cell line. Eur. J. Cell Biol.66,335–341 (1995).
  MedlineGoogle Scholar
• 243  Mauss S, Koch G, Kreye VAW, Aktories K: Inhibition of the contraction of the isolated longitudinal muscle of the guinea-pig ileum by botulinum C2 toxin: evidence for a role of G/F-actin transition in smooth muscle contraction. Naunyn Schmiedebergs Arch. Pharmacol.340,345–351 (1989).
  Medline CASGoogle Scholar
• 244  Ermert L, Brückner H, Walmrath D et al.: Role of endothelial cytoskeleton in high-permeability edema due to botulism C2 toxin in perfused rabbit lungs. Am. J. Physiol.268,L753–L761 (1995).
  Medline CASGoogle Scholar
• 245  Aktories K, Koch G: Modification of actin and Rho proteins by clostridial ADP-ribosylating toxins. In: Bacterial Toxins and Virulence Factors in Disease. Iglewski B, Moss J, Vaughan M (Eds). Marcel Dekker, NY, USA, 491–520 (1995).
  Google Scholar
• 246  Vogelsgesang M, Pautsch A, Aktories K: C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch. Pharmacol.374,347–360 (2007).
  Medline CASGoogle Scholar
• 247  Han S, Arvai AS, Clancy SB, Tainer JA: Crystal structure and novel recognition motif of Rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J. Mol. Biol.305,95–107 (2001).
  Medline CASGoogle Scholar
• 248  Vogelsgesang M, Stieglitz B, Herrmann C, Pautsch A, Aktories K: Crystal structure of the Clostridium limosum C3 exoenzyme. FEBS Lett.582,1032–1036 (2008).
  Medline CASGoogle Scholar
• 249  Evans HR, Holloway DE, Sutton JM, Ayriss J, Shone CC, Acharya KR: C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure. Acta Crystallogr. D Biol. Crystallogr.60,1502–1505 (2004).
  MedlineGoogle Scholar
• 250  Evans HR, Sutton JM, Holloway DE, Ayriss J, Shone CC, Acharya KR: The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD. J. Biol. Chem.278,45924–45930 (2003).
  Medline CASGoogle Scholar
• 251  Ménétrey J, Flatau G, Stura EA et al.: NAD binding induces conformational changes in Rho ADP-ribosylating Clostridium botulinum C3 exoenzyme. J. Biol. Chem.277,30950–30957 (2002).
  Medline CASGoogle Scholar
• 252  Menetrey J, Flatau G, Boquet P, Menez A, Stura EA: Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes. Protein Sci.17,878–886 (2008).
  Medline CASGoogle Scholar
• 253  Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I: A novel C3-like ADP-ribosyltransferase from Staphyloccocus aureus modifyng RhoE and Rnd3. J. Biol. Chem.276,9537–9542 (2001).
  Medline CASGoogle Scholar
• 254  Aktories K, Just I: Clostridial Rho-inhibiting protein toxins. Curr. Top. Microbiol. Immunol.291,113–145 (2005).
  Medline CASGoogle Scholar
• 255  Hall A: Rho GTPases and the actin cytoskeleton. Science279,509–514 (1998).
  Medline CASGoogle Scholar
• 256  Wei Y, Zhang Y, Derewenda U et al.: Crystal structure of RhoA-GDP and its functional implications. Nat. Struct. Biol.4,699–703 (1997).
  Medline CASGoogle Scholar
• 257  Bourmeyster N, Strasia MJ, Garin J, Gagnon J, Boquet P, Vignais P: Copurification of Rho protein and the Rho GDP dissociation inhibitor from bovine neutrophil cytosol. Effects of phosphoinositides on Rho ADP-ribosylation by the C3 exoenzyme of Clostridium botulinum.Biochemistry31,12863–12869 (1992).
  Medline CASGoogle Scholar
• 258  Ren XD, Bokoch GM, Traynor-Kaplan A, Jenkins GH, Anderson RA, Schwartz MA: Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in swiss 3T3 cells. Mol. Biol. Cell7,435–442 (1996).
  Medline CASGoogle Scholar
• 259  Sehr P, Gili J, Genth H, Just I, Pick E, Aktories K: Glucosylation and ADP ribosylation of Rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry37,5296–5304 (1998).
  Medline CASGoogle Scholar
• 260  Genth H, Schmidt M, Gerhard R, Aktories K, Just I: Activation of phospholipase D1 by ADP-ribosylated RhoA. Biochem. Biophys. Res. Commun.302,127–132 (2003).
  Medline CASGoogle Scholar
• 261  Genth H, Gerhard R, Maeda A et al.: Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex. J. Biol. Chem.278,28523–28527 (2003).
  Medline CASGoogle Scholar
• 262  Fujihara H, Walker LA, Gong MC et al.: Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol. Biol. Cell8,2437–2447 (1997).
  Medline CASGoogle Scholar
• 263  Barth H, Olenik C, Sehr P, Schmidt G, Aktories K, Meyer DK: Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J. Biol. Chem.274,27407–27414 (1999).
  Medline CASGoogle Scholar
• 264  Holbourn KP, Sutton JM, Evans HR, Shone CC, Acharya KR: Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase. Proc. Natl Acad. Sci. USA102,5357–5362 (2005).
  Medline CASGoogle Scholar
• 265  Pautsch A, Vogelsgesang M, Trankle J, Herrmann C, Aktories K: Crystal structure of the C3bot–RalA complex reveals a novel type of action of a bacterial exoenzyme. EMBO J.24(20),3670–3680 (2005).
  Medline CASGoogle Scholar
• 266  Ahnert-Hilger G, Holtje M, Grosse G et al.: Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones. J. Neurochem.90,9–18 (2004).
  Medline CASGoogle Scholar
• 267  Holtje M, Djalali S, Hofmann F et al.: A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J.23,1115–1126 (2009).
  MedlineGoogle Scholar
• 268  Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM: The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J.8,1087–1092 (1989).
  Medline CASGoogle Scholar
• 269  Ridley AJ, Hall A: The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell70,389–399 (1992).
  Medline CASGoogle Scholar
• 270  Fukata M, Kaibuchi K: Rho-family GTPases in cadherin-mediated cell–cell adhesion. Nat. Rev. Mol. Cell Biol.2,887–897 (2001).
  Medline CASGoogle Scholar
• 271  Aktories K, Barth H, Just I: Clostridium botulinum C3 exoenzyme and C3-like transferases. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 207–233 (2000).
  Google Scholar
• 272  Aktories K, Wilde C, Vogelsgesang M: Rho-modifying C3-like ADP-ribosyltransferases. Rev. Physiol. Biochem. Pharmacol.152,1–22 (2004).
  Medline CASGoogle Scholar
• 273  Boyer L, Doye A, Rolando M et al.: Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors. J. Cell Biol.173,809–819 (2006).
  Medline CASGoogle Scholar
• 274  Czech A, Yamaguchi T, Bader L et al.: Prevalence of Rho-inactivating epidermal cell differentiation inhibitor toxins in clinical Staphylococcus aureus isolates. J. Infec. Dis.184,785–788 (2001).
  Medline CASGoogle Scholar
• 275  O ’Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I: Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.J. Clin. Microbiol.45,1505–1510 (2007).
  MedlineGoogle Scholar
• 276  Jank T, Aktories K: Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol.16,222–229 (2008).
  Medline CASGoogle Scholar
• 277  Amimoto K, Noro T, Oishi E, Shimizu M: A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology153,1198–1206 (2007).
  Medline CASGoogle Scholar
• 278  Na X, Kim H, Moyer MP, Pothoulakis C, LaMont JT: gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect. Immun.76,2862–2871 (2008).
  Medline CASGoogle Scholar
• 279  Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK: Carbohydrate recognition by Clostridium difficile toxin A. Nat. Struct. Mol. Biol.13,460–461 (2006).
  Medline CASGoogle Scholar
• 280  Ho JG, Greco A, Rupnik M, Ng KK: Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl Acad. Sci. USA102,18373–18378 (2005).
  Medline CASGoogle Scholar
• 281  Hofmann F, Busch C, Aktories K: Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition. Infect. Immun.66,1076–1081 (1998).
  Medline CASGoogle Scholar
• 282  Hofmann F, Busch C, Prepens U, Just I, Aktories K: Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem.272,11074–11078 (1997).
  Medline CASGoogle Scholar
• 283  Rupnik M, Pabst S, Rupnik M, von Eichel-Streiber C, Urlaub H, Soling HD: Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology151,199–208 (2005).
  Medline CASGoogle Scholar
• 284  Ziegler MO, Jank T, Aktories K, Schulz GE: Conformational changes and reaction of clostridial glycosylating toxins. J. Mol. Biol.377,1346–1356 (2008).
  Medline CASGoogle Scholar
• 285  Reinert DJ, Jank T, Aktories K, Schulz GE: Structural basis for the function of Clostridium difficile toxin B. J. Mol. Biol.351,973–981 (2005).
  Medline CASGoogle Scholar
• 286  Just I, Hofmann F, Aktories K: Molecular mechanism of action of the large clostridial cytotoxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 307–331 (2000).
  Google Scholar
• 287  Busch C, Schömig K, Hofmann F, Aktories K: Characterization of the catalytic domain of Clostridium novyi α toxin. Infect. Immun.68,6378–6383 (2000).
  Medline CASGoogle Scholar
• 288  Busch C, Hofmann F, Gerhard R, Aktories K: Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases. J. Biol. Chem.275,13228–13234 (2000).
  Medline CASGoogle Scholar
• 289  Jank T, Giesemann T, Aktories K: Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J. Biol. Chem.282,35222–35231 (2007).
  Medline CASGoogle Scholar
• 290  Jank T, Reinert DJ, Giesemann T, Schulz GE, Aktories K: Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J. Biol. Chem.280(45),37833–37838 (2005).
  Medline CASGoogle Scholar
• 291  Mesmin B, Robbe K, Geny B et al.: A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity. J. Biol. Chem.279,49876–49882 (2004).
  Medline CASGoogle Scholar
• 292  Müller S, von Eichel-Streiber C, Moos M: Impact of amino acids 22–27 of rho subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and tcdB-8864. Eur. J. Biochem.266,1073–1080 (1999).
  MedlineGoogle Scholar
• 293  Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K: Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem.276,10670–10676 (2001).
  Medline CASGoogle Scholar
• 294  Fiorentini C, Thelestam M: Clostridium difficile toxin A and its effects on cells. Toxicon29,543–567 (1991).
  Medline CASGoogle Scholar
• 295  Popoff MR, Chaves-Olarte E, Lemichez E et al.: Ras, Rap, and rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem.271,10217–10224 (1996).
  Medline CASGoogle Scholar
• 296  Qa’dan M, Spyres LM, Ballard JD: pH-induced conformational changes in Clostridium difficile toxin B. Infect. Immun.68,2470–2474 (2000).
  MedlineGoogle Scholar
• 297  Qa’dan M, Spyres LM, Ballard JD: pH-induced cytopathic effects of Clostridium sordellii lethal toxin. Infect. Immun.69,5487–5493 (2001).
  MedlineGoogle Scholar
• 298  Giesemann T, Jank T, Gerhard R et al.: Cholesterol-dependent pore formation of Clostridium difficile toxin A. J. Biol. Chem.281,10808–10815 (2006).
  Medline CASGoogle Scholar
• 299  Egerer M, Giesemann T, Herrmann C, Aktories K: Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J. Biol. Chem.284,3389–3395 (2009).
  Medline CASGoogle Scholar
• 300  Egerer M, Giesemann T, Jank T, Satchell KJ, Aktories K: Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem.282,25314–25321 (2007).
  Medline CASGoogle Scholar
• 301  Reineke J, Tenzer S, Rupnik M et al.: Autocatalytic cleavage of Clostridium difficile toxin B. Nature446,415–419 (2007).
  Medline CASGoogle Scholar
• 302  Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K: Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature375,500–503 (1995).
  Medline CASGoogle Scholar
• 303  Just I, Wilm M, Selzer J et al.: The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem.270,13932–13936 (1995).
  Medline CASGoogle Scholar
• 304  Hermann C, Ahmadian MR, Hofmann F, Just I: Functional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35. J. Biol. Chem.273,16134–16139 (1998).
  MedlineGoogle Scholar
• 305  Vetter IR, Hofmann F, Wohlgemuth S, Hermann C, Just I: Structural consequences of monoglucosylation of Ha-Ras by Clostridium sordellii lethal toxin. J. Mol. Biol.301,1091–1095 (2000).
  Medline CASGoogle Scholar
• 306  Genth H, Aktories K, Just I: Monoglucosylation of RhoA at threonine 37 blocks cytosol membrane recycling. J. Biol. Chem.274,29050–29056 (1999).
  Medline CASGoogle Scholar
• 307  Halabi-Cabezon I, Huelsenbeck J, May M et al.: Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1. FEBS Lett.582,3751–3756 (2008).
  Medline CASGoogle Scholar
• 308  Chen ML, Pothoulakis C, LaMont JT: Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J. Biol. Chem.277,4247–4254 (2002).
  Medline CASGoogle Scholar
• 309  Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA: Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun.69,1329–1336 (2001).
  Medline CASGoogle Scholar
• 310  Boehm C, Gibert M, Geny B, Popoff MR, Rodriguez P: Modification of epithelial cell barrier permeability and intercellular junctions by Clostridium sordellii lethal toxin. Cell. Microbiol.8,1070–1085 (2006).
  Medline CASGoogle Scholar
• 311  Geny B, Khum H, Fitting C et al.: Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am. J. Pathol.170,1003–1017 (2007).
  Medline CASGoogle Scholar
• 312  Nottrott S, Schoentaube J, Genth H, Just I, Gerhard R: Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases. Apoptosis12,1443–1453 (2007).
  Medline CASGoogle Scholar
• 313  Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I: Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J. Med. Microbiol.57,765–770 (2008).
  Medline CASGoogle Scholar
• 314  Kim H, Rhee SH, Pothoulakis C, Lamont JT: Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. Gastroenterology133,875–886 (2007).
  Medline CASGoogle Scholar
• 315  Genth H, Dreger SC, Huelsenbeck J, Just I: Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Int. J. Biochem. Cell Biol.40,592–597 (2008).
  Medline CASGoogle Scholar
• 316  Matarrese P, Falzano L, Fabbri A et al.: Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria: involvement of ATP-sensitive mitochondrial potassium channels. J. Biol. Chem.282,9029–9041 (2007).
  Medline CASGoogle Scholar
• 317  Petit P, Breard J, Montalescol V et al.: Lethal toxin from Clostridium sordellii induces apoptotic cell death by disruption of mitochondrial homeostasis in HL-60 cells. Cell. Microbiol.5,761–771 (2003).
  Medline CASGoogle Scholar
• 318  Just I, Gerhard R: Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol.152,23–47 (2004).
  Medline CASGoogle Scholar
• 319  Gerhard R, Tatge H, Genth H et al.: Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J. Biol. Chem.280,1499–1505 (2005).
  Medline CASGoogle Scholar
• 320  Huelsenbeck J, Dreger SC, Gerhard R, Fritz G, Just I, Genth H: Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.Biochemistry46,4923–4931 (2007).
  Medline CASGoogle Scholar
• 321  Pothoulakis C, Lamont JT: Microbes and microbial toxins: paradigms for microbial-mucosa interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am. J. Physiol. Gastrointest. Liver Physiol.280,G178–G183 (2001).
  Medline CASGoogle Scholar
• 322  Savidge TC, Pan WH, Newman P, O’Brien M, Anton PM, Pothoulakis C: Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology125,413–420 (2003).
  Medline CASGoogle Scholar
• 323  Warny M, Keates AC, Keates S et al.: p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest.105,1147–1156 (2000).
  Medline CASGoogle Scholar
• 324  Na X, Zhao D, Koon HW et al.: Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology128,1002–1011 (2005).
  Medline CASGoogle Scholar
• 325  Wershil B, Castagliuolo I, Pothoulakis C: Mast cell involvement in Clostridium difficile toxin A-induced intestinal fluid secretion and neutrophil recruitment in mice. Gastroenterology114,956–964 (1998).
  Medline CASGoogle Scholar
• 326  He D, Hagen SJ, Pothoulakis C et al.: Clostridium difficile toxin A causes early damage to mitochondria in cultured cells. Gastroenterology119,139–150 (2000).
  Medline CASGoogle Scholar
• 327  Geny B, Popoff MR: Activation of a c-Jun-NH2-terminal kinase pathway by the lethal toxin from Clostridium sordellii, TcsL-82, occurs independently of the toxin intrinsic enzymatic activity and facilitates small GTPase glucosylation. Cell. Microbiol.11(7),1102–1113 (2009).
  Medline CASGoogle Scholar
• 328  Ben El Hadj N, Popoff MR, Marvaud JC et al.: G-protein-stimulated phospholipase D activity is inhibited by lethal toxin from Clostridium sordellii in HL-60 cells. J. Biol. Chem.274,14021–14031 (1999).
  MedlineGoogle Scholar
• 329  Schmidt M, Vos M, Thiel M et al.: Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. J. Biol. Chem.273,7413–7422 (1998).
  Medline CASGoogle Scholar
• 330  Kim JH, Lee SD, Han JM et al.: Activation of phospholipase D1 by direct interaction with ADP-ribosylation factor 1 and RalA. FEBS J.430,231–235 (1998).
  Medline CASGoogle Scholar
• 331  Luo JQ, Liu X, Hammond SM et al.: RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1. Biochem. Biophys. Res. Commun.235,854–859 (1997).
  Medline CASGoogle Scholar
• 332  Kelly CP, LaMont JT: Clostridium difficile – more difficult than ever. N. Engl. J. Med.359,1932–1940 (2008).
  Medline CASGoogle Scholar
• 333  Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev.18,247–263 (2005).
  Medline CASGoogle Scholar
• 334  Lyras D, O’Connor JR, Howarth PM et al.: Toxin B is essential for virulence of Clostridium difficile.Nature458(7242),1176–1179 (2009).
  Medline CASGoogle Scholar
• 335  Songer JG: Clostridial diseases in domestic animals. In: Handbook on Clostridia. Dürre P (Ed.). CRC Press, Taylor and Francis Group, FL, USA, 527–542 (2005).
  Google Scholar
• 336  Clark S: Sudden death in periparturient sheep associated with Clostridium sordellii.Vet. Rec.153,340 (2003).
  MedlineGoogle Scholar
• 337  Lewis CJ, Naylor RD: Sudden death in sheep associated with Clostridium sordellii.Vet. Rec.142,417–421 (1998).
  Medline CASGoogle Scholar
• 338  Lewis CJ, Naylor R: Sudden death in lambs associated with Clostridium sordellii infection. Vet. Rec.138,262 (1996).
  Medline CASGoogle Scholar
• 339  Al-Mashat RR, Taylor DJ: Production of diarrhea and enteritic lesions in calves by the oral inoculation of pure cultures of Clostridium sordellii.Vet. Rec.112,141–146 (1983).
  Medline CASGoogle Scholar
• 340  Richards SM, Hunt BW: Clostridium sordellii in lambs. Vet. Rec.111,22 (1982).
  Medline CASGoogle Scholar
• 341  Al-Mashat RR, Taylor DJ: Clostridium sordellii in enteritis in an adult sheep. Vet. Rec.112,19 (1983).
  Medline CASGoogle Scholar
• 342  Popoff MR: Bacteriological examination in enterotoxaemia of sheep and lamb. Vet. Rec.114,324 (1984).
  Medline CASGoogle Scholar
• 343  Bigalke H, Shoer LF: Clostridial neurotoxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 407–443 (2000).
  Google Scholar
• 344  Herreros J, Lalli G, Montecucco C, Schiavo G: Pathophysiological properties of clostridial neurotoxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 202–228 (1999).
  Google Scholar
• 345  Humeau Y, Doussau F, Grant NJ, Poulain B: How botulinum and tetanus neurotoxins block neurotransmitter. Biochimie82,427–446 (2000).
  Medline CASGoogle Scholar
• 346  Meunier FA, Herreros J, Schiavo G, Poulain B, Molgo J: Molecular mechanism of action of botulinal neurotoxins and the synaptic remodeling they induce in vivo at the skeletal neuromuscular junction. In: Handbook of Neurotoxicology. Massaro J (Ed.). Humana Press, NJ, USA, 305–347 (2002).
  Google Scholar
• 347  Meunier FA, Schiavo G, Molgo J: Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular trasnmission. J. Physiol.96,105–113 (2002).
  CASGoogle Scholar
• 348  Poulain B, Dousseau F, Colasante C, Deloye F, Molgo J: Cellular and molecular mode of action of botulinum and tetanus neurotoxins. Adv. Organ Biol.2,285–313 (1997).
  CASGoogle Scholar
• 349  Poulain B, Popoff MR, Molgo J: How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechaism of action. Botulinum J.1,14–87 (2008).
  Google Scholar
• 350  Schiavo G, Matteoli M, Montecucco C: Neurotoxins affecting neuroexocytosis. Physiol. Rev.80,717–766 (2000).
  Medline CASGoogle Scholar
• 351  Hill KK, Smith TJ, Helma CH et al.: Genetic diversity among botulinum neurotoxin-producing clostridial strains. J. Bacteriol.189,818–832 (2007).
  Medline CASGoogle Scholar
• 352  Smith TJ, Hill KK, Foley BT et al.: Analysis of the neurotoxin complex genes in Clostridium botulinum A1–A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS ONE2,e1271 (2007).
  MedlineGoogle Scholar
• 353  Smith TJ, Lou J, Geren N et al.: Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun.73,5450–5457 (2005).
  Medline CASGoogle Scholar
• 354  Arndt ER, Jacobson MJ, Abola EE et al.: A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1–A4. J. Mol. Biol.362,733–742 (2006).
  Medline CASGoogle Scholar
• 355  Chen Y, Korkeala H, Aarnikunnas J, Lindstrom M: Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol.189,8643–8650 (2007).
  Medline CASGoogle Scholar
• 356  Carter AT, Paul CJ, Mason DR et al.: Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.BMC Genomics10,115 (2009).
  MedlineGoogle Scholar
• 357  Popoff MR, Marvaud JC: Structural and genomic features of clostridial neurotoxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 174–201 (1999).
  Google Scholar
• 358  Hasegawa K, Watanabe T, Suzuki T et al.: A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J. Biol. Chem.282,24777–24783 (2007).
  Medline CASGoogle Scholar
• 359  Lietzow MA, Gielow ET, Le D, Zhang J, Verhagen MF: Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis. Protein J.27,420–425 (2008).
  Medline CASGoogle Scholar
• 360  Call JE, Cooke PH, Miller AJ: In situ characterization of Clostridium botulinum neurotoxin synthesis and export. J. Appl. Bacteriol.79,257–263 (1995).
  Medline CASGoogle Scholar
• 361  Emsley P, Fotinou C, Black I et al.: The structures of the H_c fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J. Biol. Chem.275,8889–8894 (2000).
  Medline CASGoogle Scholar
• 362  Lacy DB, Stevens RC: Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol.291,1091–1104 (1999).
  Medline CASGoogle Scholar
• 363  Lacy DB, Tepp W, Cohen AC, Das Gupta BR, Stevens RC: Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol.5,898–902 (1998).
  Medline CASGoogle Scholar
• 364  Umland TC, Wingert LM, Swaminathan S, Furey WF, Schmidt JJ, Sax M: The structure of the receptor binding fragment H_c of tetanus neurotoxin. Nat. Struct. Biol.4,788–792 (1997).
  Medline CASGoogle Scholar
• 365  Fotinou C, Emsley P, Black I et al.: The crystal structure of tetanus toxin H_c fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J. Biol. Chem.276,3274–3281 (2001).
  Google Scholar
• 366  Breidenbach MA, Brunger AT: 2.3 Å crystal structure of tetanus neurotoxin light chain. Biochemistry44,7450–7457 (2005).
  Medline CASGoogle Scholar
• 367  Fu Z, Chen S, Baldwin MR et al.: Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. Biochemistry45,8903–8911 (2006).
  Medline CASGoogle Scholar
• 368  Swaminathan S, Eswaramoorthy S: Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol.7,693–699 (2000).
  Medline CASGoogle Scholar
• 369  Stenmark P, Dupuy J, Imamura A, Kiso M, Stevens RC: Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b – insight into the toxin–neuron interaction. PLoS Pathog.4,e1000129 (2008).
  MedlineGoogle Scholar
• 370  Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S: Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J. Mol. Biol.386,233–245 (2009).
  Medline CASGoogle Scholar
• 371  Maksymowych AB, Simpson LL: Binding and transcytosis of botulinum neurotoxin by polarized human carcinoma cells. J. Biol. Chem.273,21950–21957 (1998).
  Medline CASGoogle Scholar
• 372  Maksymowych AB, Simpson LI: Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J. Pharmacol. Exp. Ther.210,633–641 (2004).
  Google Scholar
• 373  Ahsan CR, Hajnoczky G, Maksymowych AB, Simpson LL: Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J. Pharmacol. Exp. Ther.315,1028–1035 (2005).
  Medline CASGoogle Scholar
• 374  Couesnon A, Pereira Y, Popoff MR: Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cell. Microbiol.10,375–387 (2008).
  Medline CASGoogle Scholar
• 375  Matsumura T, Jin Y, Kabumoto Y et al.: The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell. Microbiol.10,355–364 (2007).
  MedlineGoogle Scholar
• 376  Jin Y, Takegahara Y, Sugawara Y, Matsumura T, Fujinaga Y: Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins – differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology155,35–45 (2009).
  Medline CASGoogle Scholar
• 377  Wellhöner HH: Clostridial toxins and the central nervous system: studies on in situ tissues. In: Botulinum Neurotoxin and Tetanus Toxin. Simpson LL (Ed.). Academic Press, CA, USA, 231–253 (1989).
  Google Scholar
• 378  Manning KA, Erichsen JT, Evinger C: Retrograde transneuronal transport properties of fragment C of tetanus toxin. Neuroscience34,251–263 (1990).
  Medline CASGoogle Scholar
• 379  Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C: Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon39,27–41 (2001).
  Medline CASGoogle Scholar
• 380  Nishiki T, Kamata Y, Nemoto Y et al.: Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem.269,10498–10503 (1994).
  Medline CASGoogle Scholar
• 381  Nishiki T, Tokuyama Y, Kamata Y et al.: The high-affinity of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides G_T1B/G_D1a. FEBS Lett.378,253–257 (1996).
  Medline CASGoogle Scholar
• 382  Jin R, Rummel A, Binz T, Brunger AT: Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature444,1092–1095 (2006).
  Medline CASGoogle Scholar
• 383  Rummel A, Karnath T, Henke T, Bigalke H, Binz T: Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem.279,30865–30870 (2004).
  Medline CASGoogle Scholar
• 384  Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER: Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol.162,1293–1303 (2003).
  Medline CASGoogle Scholar
• 385  Dong M, Yeh F, Tepp WH et al.: SV2 is the protein receptor for botulinum neurotoxin A. Science312,592–596 (2006).
  Medline CASGoogle Scholar
• 386  Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T: The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett.580,2011–2014 (2006).
  Medline CASGoogle Scholar
• 387  Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER: Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell19,5226–5237 (2008).
  Medline CASGoogle Scholar
• 388  Herreros J, Lalli G, Montecucco C, Schiavo G: Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J. Neurosci.74,1941–1950 (2000).
  CASGoogle Scholar
• 389  Herreros J, Ng T, Schiavo G: Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol. Biol. Cell12,2947–2960 (2001).
  Medline CASGoogle Scholar
• 390  Munro P, Kojima H, Dupont JL, Bossu JL, Poulain B, Boquet P: High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein. Biochem. Biophys. Res. Commun.289,623–629 (2001).
  Medline CASGoogle Scholar
• 391  Rummel A, Bade S, Alves J, Bigalke H, Binz T: Two carbohydrate binding sites in the H_cc-domain of tetanus neurotoxin are required for toxicity. J. Mol. Biol.326,835–847 (2003).
  Medline CASGoogle Scholar
• 392  Rummel A, Eichner T, Weil T et al.: Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl Acad. Sci. USA104,359–364 (2007).
  Medline CASGoogle Scholar
• 393  Rummel A, Mahrhold S, Bigalke H, Binz T: The H_cc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol. Microbiol.51,631–643 (2004).
  Medline CASGoogle Scholar
• 394  Tsukamoto K, Kozai Y, Ihara H et al.: Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. Microb. Pathog.44,484–493 (2008).
  Medline CASGoogle Scholar
• 395  Muraro L, Tosatto S, Motterlini L, Rossetto O, Montecucco C: The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem. Biophys. Res. Commun.380,76–80 (2009).
  Medline CASGoogle Scholar
• 396  Yowler BC, Schengrund CL: Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. Biochemistry43,9725–9731 (2004).
  Medline CASGoogle Scholar
• 397  Chen C, Baldwin MR, Barbieri JT: Molecular basis for tetanus toxin coreceptor interactions. Biochemistry47,7179–7186 (2008).
  Medline CASGoogle Scholar
• 398  Lalli G, Bohnert S, Deinhardt K, Verastegui C, Schiavo G: The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol.11,431–437 (2003).
  Medline CASGoogle Scholar
• 399  Lalli G, Schiavo G: Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neutrophin receptor p75^NTR. J. Cell Biol.156,233–239 (2002).
  Medline CASGoogle Scholar
• 400  Bohnert S, Deinhardt K, Salinas S, Schiavo G: Uptake and transport of clostridium neurotoxins. In: The Sourcebook of Comprehensive Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier Academic Press, Amsterdam, The Netherlands, 390–408 (2006).
  Google Scholar
• 401  Bohnert S, Schiavo G: Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. 280(51),42336–42344 (2005).
  Google Scholar
• 402  Deinhardt K, Berminghausen O, Willison HJ, Hopkins CR, Schiavo G: Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J. Cell Biol.174,459–471 (2006).
  Medline CASGoogle Scholar
• 403  Deinhardt K, Salinas S, Verastegui C et al.: Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron52,293–305 (2006).
  Medline CASGoogle Scholar
• 404  Li Y, Foran P, Lawrence G et al.: Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways. J. Biol. Chem.276,31394–31401 (2001).
  Medline CASGoogle Scholar
• 405  Maskos U, Kissa K, St Cloment C, Brulet P: Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl Acad. Sci. USA99,10120–10125 (2002).
  Medline CASGoogle Scholar
• 406  Galloux M, Vitrac H, Montagner C et al.: Membrane interaction of botulinum neurotoxin A translocation (T) domain. The belt region is a regulatory loop for membrane interaction. J. Biol. Chem.283,27668–27676 (2008).
  Medline CASGoogle Scholar
• 407  Koriazova LK, Montal M: Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol.10,13–18 (2003).
  Medline CASGoogle Scholar
• 408  Fischer A, Montal M: Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J. Biol. Chem.282,29604–29611 (2007).
  Medline CASGoogle Scholar
• 409  Montal M: Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel. Toxicon54(5),565–569 (2008).
  MedlineGoogle Scholar
• 410  Ratts R, Trujillo C, Bharti A, van der Spek J, Harrison R, Murphy JR: A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol. Proc. Natl Acad. Sci. USA102,15635–15640 (2005).
  Medline CASGoogle Scholar
• 411  Bhalla A, Chicka MC, Tucker WC, Chapman ER: Ca(2+)-synaptotagmin directly regulates t-SNARE function during reconstituted membrane fusion. Nat. Struct. Mol. Biol.13,323–330 (2006).
  Medline CASGoogle Scholar
• 412  Tucker WC, Weber T, Chapman ER: Reconstitution of Ca²⁺-regulated membrane fusion by synaptotagmin and SNAREs. Science304,435–438 (2004).
  Medline CASGoogle Scholar
• 413  Sakaba T, Stein A, Jahn R, Neher E: Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science309,491–494 (2005).
  Medline CASGoogle Scholar
• 414  Lynch KL, Gerona RR, Kielar DM, Martens S, McMahon HT, Martin TF: Synaptotagmin-1 utilizes membrane bending and SNARE binding to drive fusion pore expansion. Mol. Biol. Cell19,5093–5103 (2008).
  Medline CASGoogle Scholar
• 415  Gerona RR, Larsen EC, Kowalchyk JA, Martin TF: The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes. J. Biol. Chem.275,6328–6336 (2000).
  Medline CASGoogle Scholar
• 416  Poulain B, Stiles BG, Popoff MR, Molgo J: Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 348–389 (2006).
  Google Scholar
• 417  Foran PG, Mohammed N, Lisk GO et al.: Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, and E F compared with the long lasting type A. J. Biol. Chem.278,1363–1371 (2003).
  Medline CASGoogle Scholar
• 418  O’Sullivan GA, Mohammed N, Foran PG, Lawrence GW, Dolly JO: Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. J. Biol. Chem.274,36897–36904 (1999).
  MedlineGoogle Scholar
• 419  Keller JE, Neale EA, Oyler G, Adler M: Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett.456,137–142 (1999).
  Medline CASGoogle Scholar
• 420  Fernandez-Salas E, Steward LE, Ho H et al.: Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc. Natl Acad. Sci. USA101,3208–3213 (2004).
  Medline CASGoogle Scholar
• 421  Bajohrs M, Rickman C, Binz T, Davletov B: A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep.5,1090–1095 (2004).
  Medline CASGoogle Scholar
• 422  Jankovic J: Botulinum toxin in clinical practice. J. Neurol. Neurosurg. Psychiatr.75,951–957 (2004).
  Medline CASGoogle Scholar
• 423  Bihidayasiri R, Truong DD: Expanding use of botulinum toxin. J. Neurol. Sci.235,1–9 (2005).
  MedlineGoogle Scholar
• 424  Smith CP, Somogyi GT, Boone TB: Botulinum toxin in urology: evaluation using an evidence-based medicine approach. Nat. Clin. Pract. Urol.1,31–37 (2004).
  MedlineGoogle Scholar
• 425  Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D: Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromusc. Disord.6,177–185 (1996).
  Medline CASGoogle Scholar
• 426  de Paiva A, Meunier F, Molgo J, Aoki KR, Dolly JO: Functional repair of motor endpates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc. Natl Acad. Sci. USA96,3200–3205 (1999).
  Medline CASGoogle Scholar
• 427  Meunier FA, Lisk G, Sesardic D, Dolly JO: Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Mol. Cell. Neurosci.22,454–466 (2003).
  Medline CASGoogle Scholar
• 428  Morbiato L, Carli L, Johnson EA, Montecucco C, Molgo J, Rossetto O: Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Eur. J. Neurosci.25,2697–2704 (2007).
  MedlineGoogle Scholar
• 429  Stevens DL, Titball RW, Jepson M, Bayer CR, Hayes-Schroer SM, Bryant AE: Immunization with the C-domain of α-toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens.J. Infect. Dis.190,767–773 (2004).
  Medline CASGoogle Scholar
• 430  Baldwin MR, Tepp WH, Przedpelski A et al.: Subunit vaccine against the seven serotypes of botulism. Infect. Immun.76,1314–1318 (2008).
  Medline CASGoogle Scholar
• 431  Tavallaie M, Chenal A, Gillet D et al.: Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett.572,299–306 (2004).
  Medline CASGoogle Scholar
• 432  Aktories K: Toxins as tools. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 976–990 (2006).
  Google Scholar
• 433  Perier A, Chenal A, Babon A, Ménez A, Gillet D: Engineering of bacterial toxins for research and medicine. In: The Comprehensive Source Book of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 991–1007 (2006).
  Google Scholar
• 434  Figueiredo DM, Hallewell RA, Chen LL et al.: Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous sytem neurons by retrograde axonal transport. Exp. Neurol.145,546–554 (1997).
  Medline CASGoogle Scholar
• 435  Kominsky SL, Vali M, Korz D et al.: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am. J. Pathol.164,1627–1633 (2004).
  Medline CASGoogle Scholar
• 436  Michl P, Buchholz M, Rolke M et al.: Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology121,678–684 (2001).
  Medline CASGoogle Scholar
• 437  Jolivet-Reynaud C, Estrada J, West LA, Alouf JE, Chedid L: Targeting of G_M2-bearing tumor cells with the cytolytic Clostridium perfringens δ toxin. Anti Cancer Drugs4,65–75 (1993).
  Medline CASGoogle Scholar
• 438  Hirschberg H, Zhang MJ, Gach HM et al.: Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens ε prototoxin. J. Neurooncol. (2009) (Epub ahead of print).
  Google Scholar
• 439  Anne C, Turcaud S, Blommaert AG, Darchen F, Johnson EA, Roques BP: Partial protection against botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity. Chembiochem6,1375–1380 (2005).
  Medline CASGoogle Scholar
• 440  Sukonpan C, Oost T, Goodnough M, Tepp W, Johnson EA, Rich DH: Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease. J. Pept. Res.63,181–193 (2004).
  Medline CASGoogle Scholar
• 441  Couesnon A, Shimizu T, Popoff MR: Differential entry of botulinum neurotoxin A into neuronal and intestinal cells. Cell. Microbiol.11,289–308 (2009).
  Medline CASGoogle Scholar
• 442  Titball RW, Basak AK: Membrane-damaging and cytotoxic phospholipases. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 516–534 (2006).
  Google Scholar
• 443  Brynestad S, Granum PE: Clostridium perfringens and foodborne infections. Int. J. Food Microbiol.74,195–202 (2002).
  MedlineGoogle Scholar
• 444  Smedley JG 3rd, Fisher DJ, Sayeed S, Chakrabarti G, McClane BA: The enteric toxins of Clostridium perfringens.Rev. Physiol. Biochem. Pharmacol.152,183–204 (2004).
  Medline CASGoogle Scholar
• 445  Jestin A, Popoff MR, Mahe S: Epizootiologic investigations of a diarrheic syndrom in fattening pigs. Am. J. Vet. Res.10,2149–2151 (1985).
  Google Scholar
• 446  Miwa N, Nishina T, Kubo S, Atsumi M: Most probable number method combined with nested polymerase chain reaction for detection and enumeration of enterotoxigenic Clostridium perfringens in intestinal contents of cattle, pig and chicken. J. Vet. Med. Sci.59,89–92 (1997).
  Medline CASGoogle Scholar
• 447  Collins JE, Bergeland ME, Bouley D, Ducommun AL, Francis DH, Yeske P: Diarrhea associated with Clostridium perfringens type A enterotoxin in neonatal pigs. J. Vet. Diagn. Invest.1,351–353 (1989).
  Medline CASGoogle Scholar
• 448  Lindsay JA, Mach AS, Wilkinson MA et al.: Clostridium perfringens type A cytotoxic-enterotoxin(s) as triggers for death in the sudden infant death syndrome: development of a toxico-infection hypothesis. Curr. Microbiol.27,51–59 (1993).
  CASGoogle Scholar
• 449  Lawrence G: The pathogenesis of pig-bel in Papua New Guinea. 1979. PNG Med. J.48,39–49 (2005).
  MedlineGoogle Scholar
• 450  Hatheway CL: Toxigenic clostridia. Clin. Microbiol. Rev.3,66–98 (1990).
  Medline CASGoogle Scholar
• 451  Uzal FA, Kelly WR: Enterotoxaemia in goats. Vet. Res. Commun.20,481–492 (1996).
  Medline CASGoogle Scholar
• 452  Scholes SF, Welchman Dde B, Hutchinson JP, Edwards GT, Mitchell ES: Clostridium perfringens type D enterotoxaemia in neonatal lambs. Vet. Rec.160,811–812 (2007).
  Medline CASGoogle Scholar
• 453  Rings DM: Clostridial disease associated with neurologic signs: tetanus, botulism, and enterotoxemia. Vet. Clin. North Am. Food Anim. Pract.20,379–391, vii–viii (2004).
  MedlineGoogle Scholar
• 454  Songer JG, Miskimmins DW: Clostridium perfringens type E enteritis in calves: two cases and a brief review of the literature. Anaerobe10,239–242 (2004).
  MedlineGoogle Scholar
• 455  Baskerville M, Wood M, Seamer JH: Clostridium perfringens type E enterotoxaemia in rabbits. Vet. Rec.107,18–19 (1980).
  Medline CASGoogle Scholar
• 456  Kuijper E, de Weendt J, Kato H et al.: Nosocomial outbreak of Clostridium difficile-associated diarrhea due to a clindamycin-resistant enterotoxin A-negative strain. Eur. J. Clin. Microbiol. Infect. Dis.20,528–534 (2001).
  Medline CASGoogle Scholar
• 457  Songer JG, Anderson MA: Clostridium difficile: an important pathogen of food animals. Anaerobe12,1–4 (2006).
  Medline CASGoogle Scholar
• 458  Valiquette L, Low DE, Pepin J, McGeer A: Clostridium difficile infection in hospitals: a brewing storm. CMAJ171,27–29 (2004).
  MedlineGoogle Scholar
• 459  Weese JS, Toxopeus L, Arroyo L: Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome. Equine Vet. J.38,185–188 (2006).
  Medline CASGoogle Scholar
• 460  Oldfield EC 3rd: Clostridium difficile-associated diarrhea: resurgence with a vengeance. Rev. Gastroenterol. Disord.6,79–96 (2006).
  MedlineGoogle Scholar
• 461  Goorhuis A, Bakker D, Corver J et al.: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis.47,1162–1170 (2008).
  Medline CASGoogle Scholar
• 462  Songer JG, Uzal FA: Clostridial enteric infections in pigs. J. Vet. Diagn. Invest.17,528–536 (2005).
  MedlineGoogle Scholar
• 463  Hookman P, Barkin JS: Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol.15,1554–1580 (2009).
  MedlineGoogle Scholar
• 464  McFarland LV: Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol.3,563–578 (2008).
  Google Scholar
• 465  Kuijper EJ, Coignard B, Tull P: Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect.12(Suppl. 6),2–18 (2006).
  Medline CASGoogle Scholar
• 466  Chew SS, Lubowski DZ: Clostridium septicum and malignancy. ANZ J. Surg.71,647–649 (2001).
  Medline CASGoogle Scholar
• 467  Kornbluth AA, Danzig JB, Bernstein LH: Clostridium septicum infection and associated malignancy report of two cases and review of the literature. Medicine (Baltimore)68,30–37 (1989).
  Medline CASGoogle Scholar
• 468  Schamber GJ, Berg IE, Molesworth JR: Braxy or bradsot-like abomastitis caused by Clostridium septicum in a calf. Can. Vet. J.27,194 (1986).
  Medline CASGoogle Scholar
• 469  Borriello SP: Clostridial disease of the gut. Clin. Infect. Dis.20(Suppl. 2),S242–S250 (1995).
  MedlineGoogle Scholar
• 470  Borriello SP, Carman RJ: Association of ι-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J. Clin. Microbiol.17,414–418 (1983).
  Medline CASGoogle Scholar
• 471  Domingo RM, Haller JS, Gruenthal M: Infant botulism: two recent cases and literature review. J. Child Neurol.23,1336–1346 (2008).
  MedlineGoogle Scholar
• 472  Fu SW, Wang CH: An overview of type E botulism in China. Biomed. Environ. Sci.21,353–356 (2008).
  MedlineGoogle Scholar
• 473  Brook I: Infant botulism. J. Perinatol.27,175–180 (2007).
  Medline CASGoogle Scholar
• 474  Sobel J: Botulism. Clin. Infect. Dis.41,1167–1173 (2005).
  Medline CASGoogle Scholar
• 475  McLauchlin J, Grant KA, Little CL: Food-borne botulism in the United Kingdom. J. Public Health (Oxf.)28,337–342 (2006).
  MedlineGoogle Scholar
• 476  Aureli P, Giovanna F, Pourshaban M: Foodborne botulism in Italy. Lancet348,1594 (1996).
  Medline CASGoogle Scholar
• 477  Eklund MW, Dowell J: Avian Botulism. Charles C Thomas, Springfield, IL, USA (1987).
  Google Scholar
• 478  Smart JL: Type C botulism in intensively farmed turkeys. Vet. Rec.113,198–200 (1983).
  Medline CASGoogle Scholar
• 479  Smart JL, Roberts TA: An outbreak of type C botulism in broiler chickens. Vet. Rec.100,378–380 (1977).
  Medline CASGoogle Scholar
• 480  Degernes LA: Waterfowl toxicology: a review. Vet. Clin. North Am. Exot. Anim. Pract.11,283–300, vi (2008).
  MedlineGoogle Scholar
• 481  Gerber V, Straub R, Frey J: Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland?. Schweiz. Arch. Tierheilkd.148,553–559 (2006).
  Medline CASGoogle Scholar
• 482  Galey FD: Botulism in the horse. Vet. Clin. North Am. Equine Pract.17,579–588 (2001).
  Medline CASGoogle Scholar
• 483  Wobeser G: Avian botulism – another perspective. J. Wildl. Dis.33,181–186 (1997).
  Medline CASGoogle Scholar
• 484  Whitlock RH, Buckley C: Botulism. Vet. Clin. North Am. Equine Pract.13,107–128 (1997).
  Medline CASGoogle Scholar
• 485  Bongers JH, Tetenburg GJ: Botulism in waterfowl. Vet. Q.18(Suppl. 3),S156–S157 (1996).
  MedlineGoogle Scholar
• 486  Bergert H, Illert T, Friedrich K, Ockert D: Fulminant liver failure following infection by Clostridium perfringens. Surg. Infect. (Larchmt)5,205–209 (2004).
  MedlineGoogle Scholar
• 487  Temple AM, Thomas NJ: Gas gangrene secondary to Clostridium perfringens in pediatric oncology patients. Pediatr. Emerg. Care20,457–459 (2004).
  MedlineGoogle Scholar
• 488  Halpin TF, Molinari JA: Diagnosis and management of clostridium perfringens sepsis and uterine gas gangrene. Obstet. Gynecol. Surv.57,53–57 (2002).
  MedlineGoogle Scholar
• 489  Present DA, Meislin R, Shaffer B: Gas gangrene. A review. Orthop. Rev.19,333–341 (1990).
  Medline CASGoogle Scholar
• 490  Rood JI: Virulence genes of Clostridium perfringens. Annu. Rev. Microbiol.52,333–360 (1998).
  Medline CASGoogle Scholar
• 491  O’Rourke F, Sharrock K, Pelly M: Clostridium septicum: a malignant pathogen. J. Infect.41,286–288 (2000).
  MedlineGoogle Scholar
• 492  Smith-Slatas CL, Bourque M, Salazar JC: Clostridium septicum infections in children: a case report and review of the literature. Pediatrics117,e796–e805 (2006).
  MedlineGoogle Scholar
• 493  Barnham M, Weightman N: Clostridium septicum infection and hemolytic uremic syndrome. Emerg. Infect. Dis.4,321–324 (1998).
  Medline CASGoogle Scholar
• 494  Dirks C, Horn H, Christensen L, Pedersen C: CNS infection with Clostridium septicum.Scand. J. Infect. Dis.32,320–322 (2000).
  Medline CASGoogle Scholar
• 495  Stevens DL, Musher DM, Watson DA et al.: Spontaneous, nontraumatic gangrene due to Clostridium septicum.Rev. Infect. Dis.12,286–296 (1990).
  Medline CASGoogle Scholar
• 496  Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol – United States and Canada, 2001–2005. MMWR Morb. Mortal. Wkly Rep.54,724(2005).
  MedlineGoogle Scholar
• 497  Miech RP: Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii. Ann. Pharmacother.39,1483–1488 (2005).
  Medline CASGoogle Scholar
• 498  Wiebe E, Guilbert E, Jacot F, Shannon C, Winikoff B: A fatal case of Clostridium sordellii septic shock syndrome associated with medical abortion. Obstet. Gynecol.104,1142–1144 (2004).
  MedlineGoogle Scholar
• 499  Kimura AC, Higa JI, Levin RM, Simpson G, Vargas Y, Vugia DJ: Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin. Infect. Dis.38,e87–e91 (2004).
  MedlineGoogle Scholar
• 500  Sinave C, Le Templier G, Blouin D, Leveille F, Deland E: Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. Clin. Infect. Dis.35,1441–1443 (2002).
  MedlineGoogle Scholar
• 501  Rorbye C, Petersen IS, Nilas L: Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome. Acta Obstet. Gynecol. Scand.79,1134–1135 (2000).
  Medline CASGoogle Scholar
• 502  Abdulla A, Yee L: The clinical spectrum of Clostridium sordellii bacteraemia: two case reports and a review of the literature. J. Clin. Pathol.53,709–712 (2000).
  Medline CASGoogle Scholar
• 503  Bitti A, Mastrantonio P, Spigaglia P et al.: A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J. Clin. Pathol.50,259–260 (1997).
  Medline CASGoogle Scholar
• 504  Cunniffe JG: Clostridium sordellii bacteraemia. J. Infect.33,127–129 (1996).
  Medline CASGoogle Scholar
• 505  Spera RV Jr, Kaplan MH, Allen SL: Clostridium sordellii bacteremia: case report and review. Clin. Infect. Dis.15,950–954 (1992).
  MedlineGoogle Scholar
• 506  Buchman AL, Ponsillo M, Nagami PH: Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease. J. Infect.22,171–174 (1991).
  Medline CASGoogle Scholar
• 507  McGregor JA, Soper DE, Lovell G, Todd JK: Maternal deaths associated with Clostridium sordellii infection. Am. J. Obstet. Gynecol.161,987–995 (1989).
  Medline CASGoogle Scholar
• 508  Fischer M, Bhatnagar J, Guarner J et al.: Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N. Engl. J. Med.353,2352–2360 (2005).
  Medline CASGoogle Scholar
• 509  Rushdy AA, White JM, Ramsay ME: Tetanus in England and Wales, 1984–2000. Epidemiol. Infect.130,71–77 (2003).
  Medline CASGoogle Scholar
• 510  Simonsen O, Bloch AV, Heron I: Epidemiology of tetanus in Denmark 1920–1982. Scand. J. Infect. Dis.19,437–444 (1987).
  Medline CASGoogle Scholar
• 511  Christenson B, Böttiger M: Epidemiology and immunity to tetanus in Sweden. Scand. J. Infect. Dis.19,429–435 (1987).
  Medline CASGoogle Scholar
• 512  Izurieta H, Sutter RW, Strebel PM et al.: Tetanus surveillance – United States, 1991–1994. MMWR Morb. Mortal. Wkly Rep.46,15–25 (1997).
  CASGoogle Scholar
• 513  Tetanus among injecting-drug users – California, 1997. Morb. Mortal. Wkly Rep.47,149–151 (1998).
  MedlineGoogle Scholar
• 514  Vandelaer J, Birminigham M, Gasse F, Kurian M, Shaw C, Garnier S: Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative. Vaccine21,3442–3445 (2003).
  Medline CASGoogle Scholar
• 515  Gibson K, Bonaventure Uwineza J, Kiviri W, Parlow J: Tetanus in developing countries: a case series and review. Can. J. Anaesth.56,307–315 (2009).
  MedlineGoogle Scholar
• 516  Merson MH, Dowell RR: Epidemiologic, clinical, and laboratory aspects of wound botulism. N. Engl. J. Med.289,1005–1010 (1973).
  Medline CASGoogle Scholar
• 517  Brett MM, Hallas G, Mpamugo O: Wound botulism in the UK and Ireland. J. Med. Microbiol.53,555–561 (2004).
  MedlineGoogle Scholar
• 518  Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ: Wound botulism in California, 1951–1998: recent epidemic in heroin injectors. Clin. Infect. Dis.31,1018–1024 (2000).
  Medline CASGoogle Scholar
• 519  Akbulut D, Dennis J, Gent M et al.: Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill.10,172–174 (2005).
  Medline CASGoogle Scholar
• 520  Kalka-Moll WM, Aurbach U, Schaumann R, Schwarz R, Seifert H: Wound botulism in injection drug users. Emerg. Infect. Dis.13,942–943 (2007).
  MedlineGoogle Scholar
• 521  Burnens A: Cases of wound botulism in Switzerland. Euro Surveill.4,n5 (2000).
  Google Scholar
• 522  Alouf JE, Geoffroy C: The family of the antigenically-related cholesterol-binding (‘sulphydryl-activated’) cytolytic toxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 147–186 (1991).
  Google Scholar
• 523  Alouf JE: Cholesterol-binding cytolytic protein toxins. Int. J. Med. Microbiol.290,351–356 (2000).
  Medline CASGoogle Scholar
• 524  Basak A, Popoff MR, Titball RW, Cole AR: Clostridium perfringens ε-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 631–642 (2006).
  Google Scholar
• 525  McClane BA: Clostridium perfringens enterotoxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 763–778 (2006).
  Google Scholar
• 526  Titball RW, Rood JI: Bacterial phospholipases. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 529–556 (2000).
  Google Scholar
• 527  Chaves-Olarte E, Low P, Freer P et al.: A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial toxins. J. Biol. Chem.274,11046–11052 (1999).
  Medline CASGoogle Scholar